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SUMMARY 
Hepatocyte-based applications, such as metabolism/hepatotoxicity testing of drug-
like candidates in drug discovery, require optimal in vitro culture model for hepatocyte 
functional maintenance. Despite of the rapid emerging of novel hepatocyte 3D culture 
model with high fidelity of in vivo mimicry (i.e. 3D scaffolds, bioreactors, 
microfabricated and micro-fluidic systems), Big Pharmas currently still prefer simple 2D 
culture model (i.e. 2D hepatocyte monolayer on natural extracellular matrix-coated 
microplate) and neglect the complex 3D culture models due to their difficulties to be 
adapted to the automated high-throughput screening platform. Conventional cell culture 
microplates coated with natural extracellular matrix allow hepatocytes to adhere tightly 
as two-dimensional (2D) monolayer, but these anchored hepatocytes rapidly lose their 
differentiated functions. In this thesis, we have developed a novel 3D hepatocyte 
monolayer culture to improve the current 2D hepatocyte monolayer culture, which can be 
readily applied for high throughput drug testing and potentially useful for other 
hepatocyte-based applications such as bioreactors or for cell maintenance in the 
bioartificial-liver assisted devices. 
An overview of the background and significance of the thesis was first introduced 
in Chapter 1. Chapter 2 presented the fabrication and characterization of various 
bioactive polymeric substrata (galatosylated, GRGDS-modified and GRGDS/galactose 
Hybrid PET film) for hepatocyte culture. In Chapter 3, the dynamic process of primary 
rat hepatocyte morphogenesis cultured on the galactosylated PET film was investigated, 
which have been regulated by the balance between cell-cell interaction and cell-
substratum interaction through cytoskeletal reorganization as shown in the mechanistic 
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studies.  An interesting morphological stage, namely the pre-spheroid hepatocyte 
monolayer, was identified which exists from day 1 to day 3 after cell seeding and 
ultimately transforms into 3D hepatocyte spheroids. This novel pre-spheroid hepatocyte 
monolayer exhibits monolayer morphology and 3D cell characteristics with better cell-
cell interaction, hepatic polarity and differentiation functions than the 2D hepatocyte 
monolayer cultured on collagen coated substrate; Meanwhile, the pre-spheroid monolayer 
shows stronger adhesion to the substrate with better cell-substratum interactions than 3D 
hepatocyte spheroid without the mass transfer problem. The pre-spheroid monolayer, we 
coined the name ‘3D hepatocyte monolayer’, therefore combines the advantages of both 
gold standards of 2D and 3D hepatocyte in vitro culture models and meanwhile eliminate 
some of their instinct problems. Since the 3D hepatocyte monolayer is just a transient 
stage prior to the 3D hepatocyte spheroid formation on the galactosylated PET film, we 
employed two approaches to stabilize the 3D hepatocyte monolayer for short-term and 
longer-term applications respectively. In Chapter 4, stabilization of the 3D hepatocyte 
monolayer was achieved for one week on a GRGDS/Galactose Hybrid PET film, with 
GRGDS peptide co-conjugated on the galactosylated PET film to enhance the cell-
substrate interaction. The simple/transparent hybrid PET film can be easily incorporated 
into the microplate for drug testing. In the model drug testing in 96-well microplate, the 
3D hepatocyte monolayer exhibits similar responses to the drug-induced hepatotoxicity 
as the 3D hepatocyte spheroids, which is more sensitive to the drug responses than the 2D 
hepatocyte monolayer. In Chapter 5, a novel ECM-free synthetic sandwich culture was 
constituted for longer-term stabilization of the 3D hepatocyte monolayer by overlaying 
the 3D hepatocyte monolayer with a GRGDS-modified PET track-etched membrane as 
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top support. The 3D hepatocyte monolayer was maintained in the synthetic sandwich 
culture up to 2 weeks with improved mass transfer and higher differentiated functional 
maintenance compared to the hepatocytes in the conventional collagen sandwich culture. 
The stabilized 3D hepatocyte monolayer in the synthetic sandwich culture is potentially 
useful for drug chronic hepatotoxicity testing and bioartificial liver assisted devices. 
Finally, conclusions and discussion of the future research were made in Chapter 6.   
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Tissue engineering is an interdisciplinary research field, which leverages both 
biological understandings and engineering approaches to achieve developing biological 
substitutes to restore, maintain or argument tissue functions [1].  Generally, the 
applications in tissue engineering can include (I) therapeutic applications which involve the 
generation of functional tissue grafts in vitro and implantation in vivo to replace the 
functions of corresponding tissues and (II) diagnostic applications, in which constructs 
engineered in vitro can serves as high-fidelity models for quantitative studies of cell and 
tissue responses to genetic alternations, drugs, hypoxia, and mechanical stimuli etc. Cells or 
tissues derived from particular organs are usually cultured in vitro in diagnostic 
applications or before implantation in therapeutic applications, where they interact 
directly within different natural or synthetic biomaterials (scaffolds), for growth and 
functional maintenance. The adoptions of optimal in vitro culture models and 
biomaterials are vital for the success of tissue engineering applications. As the 
parenchymal cells of the liver, hepatocytes are notoriously difficult to maintain in vitro. 
In the field of liver tissue engineering, many attempts have been investigated to keep 
hepatocytes cultured in various in vitro culture models for hepatocyte-based applications. 
Chapter one provided an overview of hepatocyte-based applications in liver tissue 
engineering and different in vitro culture models and biomaterials used to maintain 
hepatocyte functionalities. Some of the major problems for the current in vitro culture 
models were pointed out in order to usher in the rationales to develop improved in vitro 
culture models in this thesis and highlight the significances of our work.  
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1.1       Hepatocyte-based applications in liver tissue engineering  
In the field of liver tissue engineering, primary hepatocytes are the main cell type 
used in various applications to play partial functions of the liver. This subsection first 
discussed the main functions played by the liver and hepatocytes, then provided an 
overview of the liver tissue engineering as a research field, and finally highlighted two 
important applications involved hepatocytes in the liver tissue engineering field, which 
are related to our work.   
1.1.1 Liver physiology and functions 
 
 The liver is the largest gland of the body, which normally weighs about 1.5kg in 
adult. The liver is divided into a large right lobe and a smaller left lobe. Each lobe is 
further divided into lobules, which are the functioning units of the liver (Fig. 1). The 
lobule is consisting of a hexagonal row of hepatocytes. Primary hepatocytes constitute 
60-80% of the liver mass and play many important functions in our body. The 
intercellular channels between adjacent hepatocytes form bile canaliculi, a thin tube that 
collects bile secreted by hepatocytes. The bile canaliculi merge and form bile ductules, 
which eventually become bile duct. Between each row of hepatocytes are small cavities 
called sinusoids comprising of fenestrate liver sinusoidal endothelial cells. Each sinusoid 
is lined with Kuffer cells, macrophages that remove amino acids, nutrients, sugar, old red 
blood cells, bacteria and debris from the blood that flows through the sinusoids. The main 
functions of the sinusoids are to destroy old or defective red blood cells, to remove 
bacteria and foreign particles from the blood, and to detoxify toxins and other harmful 
substances. ECM-producing Stellate cells, biliary epithelial cells, hepatocyte precursor 
cells and fibroblasts are also present and perform important metabolic functions. 
Approximately 1500ml of blood enters the liver per minute, making it one of the most 
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vascular organs in the body. Seventy-five percent of the blood flowing to the liver comes 
through the portal vein; the remaining 25% is oxygenated blood that is carried by the 
hepatic artery.  
 
Fig. 1 Architecture of liver lobule (adapted form www.ener-chi.com/d_liv.htm)  
 
The main functions played by the liver include (1) bile production and secretion; (2) 
excretion of bilirubin, cholesterol, hormones, and drugs; (3) metabolism of fats, proteins, 
and carbohydrates; (4) enzyme activation; (5) storage of glycogen, vitamins, and minerals; 
(6) macromolecule and protein synthesis (i.e. albumin, and bile acids); (7) detoxification. 
Detoxification is a critical liver-specific function. Exogenous and endogenous substances 
are detoxified in the liver by two main mechanisms, phase I and phase II 
biotransformation [2]. Phase II biotransformation involves conjugation of a substance 
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with a polar group, such as an amino acid, which detoxifies the substance or makes it 
sufficiently polar for excretion. Phase I biotransformation creates polar metabolites by 
changing functional groups (by oxidation, for example). Phase I metabolites may be 
ready for excretion but usually undergo a subsequent phase II biotransformation. Many 
phase I biotransformation reactions involve cytochrome P450 (CYP450) enzymes, which 
are localized in the endoplasmic reticulum of hepatocytes and are one of the most 
important enzyme family involved in detoxification of xenobiotics. Among the CYP 
families, CYP1, CYP2 and CYP3 family are the ones involved in xenobiotics 
metabolisms (for example CYP1A2 for caffeine, CYP2C9 for ibuprofen, CYP3A4 for 
cocaine or acetaminophen). However, in some cases, CYPs also activates prodrugs (i.e. 
cyclophosphalmide) or procarcinogens (i.e. aflatoxin B1) which become toxic through 
this reaction.  
 
1.1.2 Overview of liver tissue engineering 
 
Liver tissue engineering is a cross-disciplinary field including, but not limited to, 
developmental biology, biochemistry, molecular biology, materials science, and 
biomedical engineering. The research in this field started more than 30 years ago when 
investigators dissatisfied with the hazards, difficulties and inconsistencies associated with 
hepatic support systems using transplanted hepatocytes as free grafts (direct injection of 
hepatocytes into various organs, body cavities, or blood vessels) [3-5]. Several 
hepatocyte culture systems have been tried in 80s as alternatives to improve the direct 
injection strategy, which include microcarriers (attachment of hepatocytes to type I 
collagen-coated dextran beads) [6, 7], hepatocytes encapsulation in biocompatible 
membranes [8], and biodegradable polymers (originally developed as drug delivery 
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vehicles) [9, 10]. After more than 30 years’ development, the efforts in the modern liver 
tissue engineering field mainly include: 1) creating a whole, implantable, and functional 
tissue-engineered liver construct; 2) establishing bioartificial liver systems to sustain liver 
patient's lives before liver transplantation, establishing in vitro hepatocyte-based model 3) 
establishing culture model for drug metabolism/toxicity screening for drug discovery and 
4) for basic researches of liver regeneration, disease, pathophysiology and pharmacology. 
All the above-mentioned efforts must consider both the source of hepatocytes and the 
approaches to maintain liver specific function of the cells.  
The option of cell source is important because it is necessary to choose cells that 
demonstrate the particular phenotype of interest. The various cell types that have been 
studied include mature hepatocytes, cell lines and stem cells [11-13]. Primary 
hepatocytes are the most common cellular component with many examples using readily-
available porcine or rat hepatocytes. Primary human cells are a preferred cell source, but 
due to limited supply, their wide applications have been greatly hampered. The 
development of highly functional hepatocyte cell lines is an obvious strategy to overcome 
the growth limitations of primary cells. All the cell lines are growth competent but they 
only exhibit partial of the liver specific functions and may have safety problem due to 
their tumor origin [11]. Stem cells are very promising cell source with the ability to self-
renewing and differentiation into hepatocyte-like cells. Potential stem cell sources are 
embryonic stem cells, fetal liver cells, adult liver progenitors, and trans-differentiated 
non-hepatic cells. The liver stem cell field is very active in recent year which have been 
reviewed by several researchers [14, 15]. Besides cell source, another important factors to 
determine the success of liver tissue engineering application is the approaches adopted to 
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maintain and stabilize liver specific functions, which will be discussed in detailed in the 
later part of the introduction. In the next subsection, we will review two important 
hepatocyte-based applications in the liver tissue engineering field, namely in drug 
metabolism/hepatotoxicity testing and BLAD applications, which are most related to our 
project.  
 
1.1.3 Hepatocyte-based drug metabolism/hepatotoxicity screening  
Advances in genomics, proteomics and synthetic chemistry have revolutionized 
drug discovery and have already provided the pharmaceutical industry with a rapidly 
increasing number of drug-like candidates. ADME/T drug properties, namely, absorption, 
disposition, metabolism, elimination and toxicity, are important properties critical for 
clinical success of a new drug [16]. Accurate prediction of drug ADME/T is one of the 
most important screening step before the clinical trials of the new drug candidates (Fig. 2) 
and remains the major challenge for the pharmaceutical industry as evidenced by the 
yearly withdrawal or severe use limitation of marketed drugs due to unexpected adverse 
effects (lack of efficacy, toxicity, and unfavorable pharmacological properties) [17]. As 
the one of the main type cells in our body to detoxify and metabolize foreign substances 
including drugs, primary hepatocytes have long been used by pharmaceutical companies 
to test the metabolic profiles and toxicity of hundreds of thousands of drug-like chemical 
compounds in order to screen out the promising candidates which can then enter the 
following animal testing and pre-clinical trials. The purpose of hepatocyte-based drug 
metabolism/toxicity screening is to achieve the so-called 3Rs: replacement (of whole 
animal); reduction (of animal use); and refinement (of metabolic or toxicity assays).The 
advantages of hepatocytes-based screening are the retainment of species-specific 
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metabolism (especially the P450 metabolic enzymes), and the requirement of relatively 
low amount of test materials. The disadvantages of hepatocytes-based screening are the 
lack of host factors and the lack of non-parenchymal cells.  
Drug metabolism studies can first predict whether orally administered drugs are 
extensively metabolized by the P450 enzymes in the liver before the drugs enter the 
systemic circulation (we either have to administer them by a route that avoids the liver or 
chemically modify them so that they are less prone to metabolism yet retain the desired 
pharmacologic activity); second, can provide information on which P450 enzyme 
metabolizes a drug which help predict or explain drug interactions. Over 150 highly  
 
Fig. 2 Drug-discovery pipeline: the ADME & Toxicology strategies are important 
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related forms of cytochrome P450 enzymes (isoforms, or isoenzymes) have been 
characterized which have been grouped into families on the basis of structural and 
functional features. Only about seven of the families are important for drug metabolism. 
The cytochrome P450 3A group (CYP3A) is responsible for metabolism of over 50% of 
the drugs that depend upon metabolism for elimination. Two other important families are 
the cytochrome P450 2D6 and 2C groups (CYP2D6 and CYP2C, respectively) [19]. 
Endogenous substances such as steroid hormones and bile salts are also substrates for 
cytochrome P450 enzymes in the liver and other organs.  
Hepatocyte-based hepatotoxicity testing is mostly useful in the rapid screening of 
chemicals and in the mechanistic evaluation of toxicological phenomena. A large amount 
of natural and synthetic chemicals are hepatotoxins. In many cases, the toxicity is 
metabolism-mediated caused from the metabolic conversion (bio-activation) of the parent 
compound into highly reactive metabolites. AAP, carbon tetrachloride, 
dimethylnitrosamine, and halothane are examples of xenobiotics that are “bioactivated” 
by CYP mono-oxygenases in the liver [20]. Species differences in xenobiotics 
metabolism are therefore important factors contributing to the known species differences 
in chemical toxicity.  The hepatocytes therefore are usually the first cell types that are 
damaged upon hepatotoxic insult. The hepatocytes-based screening can be used to 
characterize the metabolic fate of compounds and whether metabolism contributes to 
toxicity. For example, primary hepatocyte cultures can be used to assess the potential for 
drug-drug interactions, such as CYP450 induction by a compound, and to identify 
metabolites. Additional in vitro metabolic assessments include determination of whether 
a compound is a significant substrate for specific phase I enzymes using isolated 
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microsomal or supersome preparations (metabolic stability) or phase II enzymes using 
primary human hepatocytes, whether a compound acts as an inhibitor of a particular 
CYP450 enzyme, and whether a formed metabolite is reactive, leading to 
macromolecular adduct formation or to enzymatic inactivation. In vitro systems are 
extremely useful for mechanistic evaluations. This is probably the most important aspect 
of in vitro toxicology. Via the elucidation of mechanisms, one can extrapolate from high 
to low doses, from one species to another, and from acute to chronic exposure. The 
importance of hepatocytes-based in vitro systems may not be in the prediction of human 
toxicity per se, but in bridging the gap between laboratory animals and humans to allow a 
better prediction of human toxicity based on whole animal data.  
Today, most pharmaceutical companies use a set of specific high-throughput 
screening (HTS) assays as the initial step in drug lead discovery [21]. HTS assays in 96-
well plates are being developed for major drug properties that are critical to the clinical 
success of a drug candidate: metabolic stability, toxicological potential, and inhibitory 
drug-drug interaction potential. The use of the 96-well plate format allows automation 
and minimizes that amount of experimental materials required. Most high throughput 
methods typically use a plate reader for end-point scanning, in combination with a liquid-
handling robot, for transferring reagents in a well-plate format. To increase throughput, 
the trend is to use a higher number well plates, where the difference between a 96-, 384-, 
1,536- and 3,456-well plate means 300, 50, 10 and 2 µl per well, respectively. Besides 
the efforts to achieve the ultra-throughput, a lot of work in the field of tissue engineering 
has been contributed to design novel, more complex in vitro hepatocyte test systems (i.e. 
Multicellular 3D spheroid model [22], sandwich culture model [23], perfusion bioreactor 
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model [24], and miniaturized systems like ‘microfluidic biochip’ [25]), which is able to 
achieve high fidelity of drug responses as the hepatocytes in vivo [26, 27]. 
 
1.1.4 Hepatocyte-based bioartificial liver assisted devices (BLAD) 
Another important hepatocyte-based application is related to BLAD, which is used 
to temporarily replace the liver functions of the ALF patients. ALF is associated with a 
very high mortality rate. The loss of liver functions such as detoxification, metabolism, 
and regulation causes life-threatening complications, including kidney failure, 
encephalopathy, cerebral edema, severe hypotension and susceptibility to infections 
culminating in multiple organ failure. Orthotropic liver transplantation is currently the 
only established treatment of choice for patients with ALF. However, there is a severe 
shortage of liver donors and patients cannot survive until a donor organ is available. The 
need for livers far outpaces the number of donations. The 2006 OPTN/SRTR annual 
report shows that in 2005, ~13,000 people are waiting to receive a liver transplantation in 
the United States, yet there are only 6,441 liver transplantations performed during the 
year. Currently one-third of patients die while waiting for transplantation. Attempts to 
provide temporary liver supports for liver failure patients have been investigated since 
1970s. Both non-biological (charcoal resins and dialysis) and biological (blood exchange 
and animal organ perfusion) approaches have been implemented with limited therapeutic 
benefits [28]. Therefore, A BLAD, an extracorporeal bioreactor incorporated with animal 
cells or human hepatic cell lines, has been proposed to provide a full complement of liver 
functions and bridge the waiting period of the ALF patients for liver transplantation.  
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In a BLAD, hepatocytes are usually cultured inside a bioreactor connected to the 
patient’s circulation system where nutrients and wastes can be exchanged between the 
patient plasma and the hepatocytes. Perfusing plasma instead of whole blood eliminates 
the problems caused by hemolysis, thrombocytopenia, clot formation, embolization and 
the need to use heparin. Different types of liver cells can be loaded in BLADs. Primary 
human hepatocytes are the optimal choice, but the cell source is quite limited and 
extremely expensive. Primary cells from other species (i.e. porcine, rat, rabbit) have been 
used, which have to incorporate proper immuno-isolation strategies to prevent the 
immunological reactions to different species. Transformed human liver cell lines are an 
alternative as they are immortal, their culture is easier, and they can reach a higher 
cellular density. However, cell lines are inferior to primary cells in accomplishing hepatic 
functions and bear the potential risk of tumor transmigration from the BLAD into the 
patient’s circulation. The design of optimal in vitro configurations for hepatocyte 
functional maintenance inside the bioreactor is one of the core technologies to determine 
the performance of a BLAD [29].  Different culture configurations adopted in a BLAD 
include: Suspension culture [30]; Microcarriers[31, 32]; Encapsulation[33, 34] Hollow 
fiber [35]; Monolayer culture [36]; Sandwich culture [37]; Co-culture [38]; Hydrogel 
incorporated within scaffolds [39]; 3D hepatocyte spheroids [40]; 
Since 1990, 9 BLAD systems have been clinically tested, most of which utilize a 
hollow fiber technology, and a much larger number of BLAD systems in preclinical test 
have been suggested to show an enhanced performance [41, 42]. They are ELAD [43], 
HepatAssist [32],LSS [44], BLSS [45], RFB [46] and AMC [47]. The rest three are quite 
similar to HepatAssist [48-50]. In the ELAD system, ~200 g of C3A, a human 
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hepatoblastoma cell line, are cultured in modified dialysis cartridges. The cells are 
located in the extracapillary space of the hollow fiber, and are separated from plasma by 
the capillary membranes. Before entering the bioreactor, the plasma passes a charcoal 
absorber for detoxification and a membrane oxygenator for oxygen enrichment. The 
ELAD has entered first clinical trial to demonstrate the safety of the system. HepatAssist 
is a system that uses 5–7 x109 cryopreserved porcine hepatocytes in a similar setting as 
ELAD. Clinical study with a total of 171 patients (86 in the control group and 85 in the 
bioartificial liver treatment group) was conducted for patients with 
fulminant/subfulminant hepatic failure and primary non-function after liver 
transplantation. HepatAssist demonstrated the safety and improved 30-day survival in a 
subgroup. LISS consists of a unique bioreactor with four different hollow fibers, which 
are woven into 3D lattice. These hollow fibers independently provide oxygen/nutrient 
supply and the exchange with the plasma simultaneously. The LISS is the only system 
that uses primary human hepatocytes isolated from discarded donor livers as well as 
porcine hepatocytes. In phase I of a study using human hepatocytes, the LSS was 
combined with a single-pass albumin dialysis (MARS), called MELS. Both LSS and 
MELS have been reported to successfully support six patients. In BLISS, primary porcine 
hepatocytes were mixed with a collagen gel first and infused into the extracarpillary 
space of the cellulose acetate hollow fibers. The blood ammonia levels decrease by 33% 
compared with the initial level. For RFB, the patient’s plasma passed from the center to 
the peripheral of the hollow fiber module. The RFB decreased a mean ammonia and 
bilirubin level by 33% and 11% respectively. Within the AMC, in contrast to all other 
mentioned systems, the capillary membranes exclusively serve oxygenation. The cell 
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compartment of the device, which has a polyester matrix, is loaded with about 200 g of 
primary porcine hepatocytes. During therapy, the matrix is directly perfused by patient 
plasma.13 phase I study showed the safety of the treatment. 
Besides being useful as a temporary replacement of liver functions, a BLAD can 
also be applied to synthesize cellular products [51]. Tumor-derived cell lines are cultured 
in BLAD to achieve a continuous secretion, an easier purification and a good yield of 
cellular products. As an example, purified hepatitis B surface antigen can be produced 
from Alaxander hepatoma cells grown in BLAD [52]. 
 
1.2       In vitro hepatocyte culture models in hepatocyte-based applications  
The ultimate goal of tissue engineering is to build artificial systems in vitro which 
can play part of or even replace the functions of particular organs in vivo. Establishing 
optimal in vitro hepatocyte culture models for hepatocyte functional maintenance is vital 
for the success of hepatocyte-based applications. Nature has created the best systems for 
us to follow. In this subsection, approaches for hepatocyte functional maintenance in 
vitro were first discussed in general; then various in vitro culture models for hepatocyte 
functional maintenance were reviewed; finally followed by the introduction of three 
specific hepatocyte culture models which are closely related to our work; 
 
1.2.1  Overview of various approaches for hepatocyte functional maintenance in vitro  
The in vivo microenvironment experienced by hepatocytes provides references in 
engineering culture environments for hepatocytes in vitro. The optimal function of 
hepatocytes in vivo is maintained by a complex synergy of extracellular cues including 
soluble factors, extracellular matrix and homotypic/heterotypic cell-cell interactions. 
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Regulated by these extracellular cues, hepatocytes exhibit different polarized domains of 
the plasma membrane associated with distinct functions: the sinusoidal (basal) domain in 
contact with loose ECM for the exchange of metabolites; the intercellular (lateral) domain to 
mediate hepatocytes homotypic cell-cell adhesions; and the canalicular (apical) domain 
specialized for the secretion of bile acid to the bile ductules [53].  
To recapitulate the physiologically relevant extracellular cues, several distinct 
approaches should be considered to adopt synergistically, when build in vitro hepatocyte 
culture model to promote hepatocyte functional and polarity maintenance. 1): to mimic the 
physiological milieu of the soluble factors, hepatocyte culture medium have been modified 
with hormonally-defined components, such as low concentrators of hormones, corticosteroids, 
cytokines, vitamins or amino acids or the addition of low levels of dimethyl sulfoxide or 
dexamethasone, which have been shown to help promote a stabilized hepatocyte phenotype 
[54-56]. 2) Extracellular matrix of various compositions is known to mediate the cell-matrix 
interaction and exhibit positive effects on hepatocyte function and polarity. The matrix used 
for liver engineering will be discussed in detail in the following part. 3) Hepatocyte 
homotypic interactions have been highlighted to be vital for enhancing the hepatocyte 
functional and polarized features. Examples for the enhancement of homotypic interactions 
include the hepatocytes spheroids and aggregates formed in suspension or on non-adherent 
substrates to promote the formation of bile canaliculi, gap junctions, and tight junctions [57, 
58]; and the sandwich culture of hepatocytes within collagen gel or culture on the tumor-
derived basement preparation Matrigel [59]; 4) Heterotypic interactions have also contributed 
to improve the hepatocytes viability and differentiated function, which has been reported for 
hepatocyte co-cultures with both liver- and non-liver-derived cell types and, furthermore, 
beneficial effects of cross-species co-culture systems have also been observed [60, 61]; 5) 
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Flow conditions are another key regulator of hepatocyte functions. Perfusion systems in 
scaffolds or bioreactors would facilitate enhanced nutrient delivery to hepatocytes and waster 
excretion from the highly metabolic hepatocytes [11]; 6) Mechanical stress has been shown 
to regulate the expression of certain gene which is vital for hepatocyte phenotypic 
maintenance [51, 62];  
In summary, Mother Nature has highlighted great importance of micro-environmental 
signals for the functional and polarization maintenance of hepatocytes, including soluble 
factors, cell-matrix interactions, cell-cell interactions, flow conditions and mechanical stress. 
Accordingly, the development of optimal hepatocyte in vitro culture model has taken 
references of a fundamental knowledge and controlled reconstitution of these environmental 
factors. Major hepatocyte in vitro culture models in the liver tissue engineering are listed in 
Table 1. Next we will discuss three in vitro culture models in details, namely 2D monolayer 
culture, sandwich culture and 3D spheroid culture, due to their relevance to the novel 3D 
hepatocyte monolayer culture model we have developed in this thesis. 
 
















2D monolayer culture  [36, 65, 66] 





































































1.2.2 2D hepatocyte culture model 
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2D hepatocyte cultured is the most conventional and widely-used model to facilitate 
the hepatocyte adhesion on the substratum for survival.  Hepatocytes are normally plated 
on cell culture plate or plastics coated with extracellular matrix, such as collagen, 
fibronectin, laminin or conjugated with cell adhesion peptide, such as Arg-Gly-Asp 
(RGD) and Tyr-Ille-Gly-Ser-Arg (YIGSR) [88].  Hepatocytes anchor tightly to these 
substrata, and exhibit extended and spreading cell morphology, with low levels of liver-
specific functions likely due to hepatocyte de-differentiation Cell adhesion is mediated in 
part by cell-membrane-bound receptors (in particular, integrins, a family of heterodimeric 
transmembrane proteins that are linked to the cytoskeleton on the cytoplasmic side of the 
membrane) [89], which recognize specific peptide sequences present in the extracellular 
matrix (ECM) proteins. Integrins aggregate in organized structures termed focal contacts, 
which establish a mechanical link between the membrane and the ECM substrate and 
between the ECM and the cytoskeleton. Hepatocytes cultured in 2D normally exhibit 
intense F-actin stress fiber and highly aligned distribution of microtubule cytoskeleton 
[90].  
Due to the technical simplicity and reproducibility, hepatocyte 2D monolayer 
configuration has been the golden standard used by pharmaceutical industry for new drug 
toxicity screening [17], where hepatocyte 2D monolayer are normally cultured on the 
collagen-coated microplates allowing high-throughput screening of hundreds of 
thousands of  drug candidates. The 2D hepatocyte culture has also been used as a vital 
component in many other more complex culture models for cell adhesion and survival, 
such as ‘flat-plate bioreactor’ [91, 92], microfabricated and microfluidic systems [25]. 
The hepatocytes culture in 2D lost their differentiated phenotype such as liver-specific 
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functions, polarized structure and expressions of metabolic enzymes rapidly. Many 
studies have shown that there are tremendous differences of gene expression, protein 
express and biochemical activity between 2D culture and 3D culture, which are more 
mimic to in vivo. The current trend in tissue engineering has been focusing on 
establishment of 3D culture model to improve the in vivo mimicry.  
 
1.2.3 Sandwich hepatocyte culture model  
The deteriorating process of 2D hepatocyte culture could be rescued by overlaying 
another ECM layer on top, which mimics the ECM distribution in the space of Disse [93]. 
Hepatocyte sandwich culture between double layers of ECM is an ideal in vitro model 
with re-established hepatic polarity and stable liver-specific functions [93-95]. The most 
common matrices for sandwich cultures are collagen type I and Matrigel. Collagen-
Matrigel sandwiches have been shown to have some advantages over collagen-collagen 
sandwiches, such as expression of the gap junction protein connexin 32 and the 
expression of the epidermal growth factor receptor.  However, Matrigel are significantly 
more expensive than collagen, and there are many batch-to-batch variations, thus most 
studies in a sandwich culture have been carried out in collagen-collagen sandwiches. 
Hepatocytes in sandwich culture have been shown to maintain their polygonal 
morphology and liver-specific functions for several weeks. In addition, they maintain 
biliary excretion, CYP1A and CYP3A, sulfo-and glucuronsyltransferases, as well as 
glutathione S-transferase. Microtubule in sandwiched hepatocytes was organized into a 
dense meshwork. F-actin in hepatocytes cultured in a double collagen gel was 
concentrated under the plasma membrane in regions of contact with neighboring cells, 
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which is similar to what was observed in vivo. It has been demonstrated that a contiguous 
network of bile canaliculi was formed throughout the entire sandwich culture [67].  
The hepatocyte sandwich culture has been adopted in liver physiology studies [96, 
97], drug metabolism/toxicity testing [98] and hepatocyte-based bioreactors [99, 100]. 
Further applications of the conventional ECM-based sandwich culture were hampered by 
the complex molecular compositions of the ECM with batch to batch variation [101], 
uncontrollable ECM coating, mass transfer barriers induced by the gelled ECM-coated 
top support (hindering the exchange of nutrients, xenobiotics or biochemical signals with 
the bulk culture medium), and shedding of the ECM coat from the top support during 
culture.  
 
1.2.4 3D hepatocyte spheroid culture model 
Another gold-standard of hepatocyte culture model in liver tissue engineering is 3D 
hepatocyte spheroid where isolated hepatocytes in vitro self-assemble into multicellular 
spherical aggregates. 3D hepatocyte spheroids have been obtained in suspension culture 
[30] and on numerous moderately-adhesive substrata comprised of natural matrices such 
as proteoglycan fraction from liver reticulin fibers [102], agarose [103], rigid 
extracellular matrix at low concentration like Matrigel, laminin, fibronectin or collagen I 
[104],  artificially synthetic matrices such as positively charged [105] or galactosylated 
[106] substrata, and microfabricated systems like microwells [77].  
Hepatocytes spheroids are believed to re-establish in vivo-like 3D architectures and 
associated cell-cell/cell-matrix interactions with enhanced hepatocyte differentiated 
functions,  polarities and liver tissue-structures such as the well-established bile canaliculi, 
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tight junctions and gap junctions [107]. Spheroids are also reported to maintain several 
liver-specific functions such as albumin secretion and cytochrome P450 detoxicification 
activity in culture for weeks. The features of the hepatocyte spheroid potentially make it 
an optimal culture configuration as compared to hepatocyte 2D monolayer for 
hepatocyte-based applications. 3D hepatocyte spheroids have been useful in applications 
such as bio-artificial liver-assisted devices (BLAD) [108] and drug 
metabolism/hepatotoxicity studies [109, 110]. The usefulness of 3D hepatocyte spheroids 
in applications is limited due to the poor mass transport of nutrients, oxygen, xenobiotics 
and metabolites into and from the core of these large cellular aggregates [111, 112]. Cell 
loss is also a critical issue in forming and maintaining these spheroids in applications 
since the spheroids detach easily from the substratum[113, 114]. 
 
1.3   Natural and synthetic biomaterials for hepatocyte culture 
Hepatocytes are anchorage-dependent cells and highly sensitive to the extracellular 
environments for the maintenance of their viability and differentiated functions. 
Biomaterials provide a template for cell attachment and tissue development. One of the 
major challenges in BLAD design and drug metabolism/toxicology studies is to develop 
optimal substrata for hepatocyte attachment and functional maintenance. This subsection 
first reviewed a variety of natural as well as synthesized polymeric substrata employed to 
establish different hepatocyte culture models; followed by a more detailed introduction of 
RGD peptide-modified and galactosylated biomaterials for hepatocyte culture, which are 
closely related to the biomaterial developed in this thesis; finally, the current 
understandings of the mechanisms governing the hepatocyte adhesion and 3D spheroid 
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formation were discussed in order to lay the foundation of our mechanistic study of 
hepatocyte morphogenesis regulated by microenvironment in vitro. 
 
1.3.1 Overview of the natural and synthetic biomaterials for hepatocyte culture 
Besides contacting with each other and aligning in cell sheets, primary hepatocytes 
in vivo directly interact with only ECM in the Space of Disse. The ECMs provide not 
only physical support but also regulation of hepatocytes functions and behaviors. ECMs 
in the liver mainly contain collagen IV, I, laminin, fibronectin and heparan sulfate 
proteoglycon [115, 116]. Therefore, the most widely-used natural matrices for 
hepatocytes culture include collagen and other ECM glycoproteins like fibronectin and 
laminin. Primary hepatocytes typically exhibited good attachment and formed monolayer 
when cultured on those substrata. Another natural substratum for the study of hepatocyte 
aggregation is the basement membrane derived gel, known as Matrigel, which is 
reconstituted from the secreted extract of an Englebroth–Holm–Swarm (EHS) sarcoma 
and mainly contains collagen IV, laminin or heparan sulfate proteoglycon [115, 116]. 
Hepatocytes were shown to exhibit rapid morphogenesis on Matrigel, forming columns 
with minimal spreading that express high levels of liver-specific differentiated function, 
however, hepatocytes lost the good functions and became spreading when seeded on each 
component of Matrigel alone [115]. That may indicate synergistic interplays among 
different components of the Matrigel in order to retain the hepatocytes morphology and 
functions.    
Besides the natural matrices, the synthetic polymeric scaffolds have been widely 
used in works in liver tissue-engineering. A biomaterial scaffold provides a template for 
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cell attachment and tissue development, and in many cases, it biodegrades in parallel with 
the accumulation for tissue components. Scaffold structure determines the transport of 
nutrients, metabolites and regulatory molecules to and from the cells, and the scaffold 
chemistry may have an important signaling role. Scaffolds vary with respect to material 
chemistry, geometry, topology, hydrophobicity, charges, mechanical properties, and the 
sensitivity to and rate of degradation. some polymer scaffolds used in liver tissue 
engineering include [117]: polyglycolic acid (PGA), polylactic acid (PLA), polylactic 
glycolic acid (PLGA), polycaprolactone (PCL), poly-b-hydroxybutyrate (PHB), 
polyurethane, polycarbonate (PC), poly(vinyl alcohol) (PVA), poly(ethylene oxide) 
(PEO), polyethylene glycol (PEG), biorubber, and thermo-responsive polymer poly N-
isopropyl acrylamide (PNIPAAm). Since most of the polymeric materials are lack of 
specific functional groups to interact with cells, surface modification of the polymeric 
scaffolds with signaling molecules is adopted to facilitate the cell-biomaterials interaction 
as well as addressing the fouling issue due to the non-specific protein absorption. Useful 
to tissue engineering are modifications using cell adhesion receptors. The cell surface 
receptors recognize and bind or block a specific signaling molecule that is bound to the 
surface of the polymer. This allows for the polymer to interact with a specified cell. 
Signaling molecules for surface modification are proteins (i.e. fibronectin, laminin, 
collagen, elastin, and vitronectin), peptides (i.e. RGD and YIGSR) of various lengths, and 
carbohydrate (i.e.galactose, glucose and fructose) [106, 118]. These modifications 
provide the seeded cells with the proper environmental cues, factors for growth, and 
either a prevascularized site or a porous structure allowing for angiogenesis. Therefore, 
the modified polymers are known as bioactive polymers.  
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1.3.2 RGD-modified biomaterials for hepatocyte culture 
The RGD (Arg,Gly,Asp) tripeptide is recognized as the active sequence of adhesive 
proteins of the extracellular matrix (ECM) that binds to integrin receptors [119]. Integrins 
are trans-membrane receptors for extracellular matrix proteins, which mediate cell-
substratum interaction leading to adhesion and spreading of the cells. The combination of 
different alpha and beta chains gives rise to the presence of 22 integrins described in 
literature so far [89]. In primary hepatocytes, the integrin beta1 is the major type of 
integrin found to interact with collagen type I in vivo [120]. These receptor proteins not 
only allow binding to matrix proteins, but are also thought to be involved in signaling 
events towards gene transcription and cell proliferation. Arg-Gly-Asp (RGD) have been 
conjugated onto different substrata for hepatocyte culture (Table 1). Hepatocytes attach 
well to these substrates by exhibiting the spreading morphology. Previous study has 
shown that 0.1 pmol/cm2 of ECM protein on the substratum could be enough to promote 
cell adhesion and spreading [121]; In general, hepatocytes cultured on RGD substrata still 
exhibit low levels of liver-specific functions, reflecting hepatocyte dedifferentiation [122].  
 
Table. 2 Summary for previous RGD bearing biomaterials for hepatocytes culture 
Descriptions References  
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RGD conjugated in a synthetic copolymer bearing a sugar moiety for improved 
culture of hepatocytes. 
 
[125] 




Modification of polyethersulfone membranes by plasma polymerization of 
acrylic acid monomers and by immobilization of RGD peptide through a 
hydrophilic "spacer arm" molecule. 
 
[127] 









1.3.3 Galactosylated biomaterials for hepatocyte culture 
Galactose-conjugated substrata are attractive alternatives for hepatocyte culture. 
Hepatocyte adhesions were mediated through the specific interaction of cell membrane 
asialoglycoprotein receptor (ASGPR) with the galactose moiety [130]. 
Asiaioglycoprotein receptor (ASGP-R) is a major protein on the sinusoidal, or blood-
facing side of the hepatocyte plasma membrane. ASGPRs are known to bind to galactose 
or N-acetylgalactosamine terminated ligands in a calcium-dependent manner [131]. This 
galactose lectin apparently removes certain glycoproteins that have abnormal 
oligosaccharides from the circulation. The receptor-ligand complexes are internalized by 
clathrin-coated vesicles and delivered to an acidic endosomal compartment where they 
dissociate. The receptors recycle to the plasma membrane, whereas ligands are 
transported to lysosomes and degraded. Murine ASGPR was identified to be composed of 
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two highly homologous subunits, murine hepatic lectin 1 (MHL-1) as a major subunit (42 
kDa) and MHL-2/3 as a minor subunit (45 and 51 kDa) [132]. Although ASGPR is a 
physiologically non-adhesion cell membrane receptor, ASGPR-galactose interaction has 
been used to induce selective adhesion to primary hepatocytes. The characteristic 
attribute of these galactosylated substrata is the propensity of hepatocytes to keep round 
shape and form aggregates or spheroids mediated by the galactose-ASGPR interaction, in 
concomitance with maintaining higher differentiated functions [106]. Hepatocyte 3D 
spheroids have been formed on various polymeric biomaterials conjugated with galactose 
ligands such as PET, PVDF and PCL and have been applied for BLAD with optimal 
performances [81].  Several strategies have been applied to fabricate substrata conjugated 
with galactose ligands, which show improved hepatocyte functional maintenance (Table 
2). 
 
Table. 3 Summary for the galactosylated substrata for hepatocytes cultures 
 
Descriptions References




Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels [134] 
Alginate/Galactosylated Chitosan/Heparin scaffold as a new synthetic extracellular 
matrix for hepatocytes 
 
[135] 
Galactosylated alginate as a substratum for hepatocytes entrapment. [136] 
Microdistribution of substratum-bound ligands affects cell function: hepatocyte 
spreading on PEO-tethered galactose 
[137] 
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Conjugation of galactose ligands on acrylic acid graft copolymerized poly(ethylene 
terephthalate) film and its application to hepatocyte culture 
 
[140] 




1.3.4 Current understandings of the morphogenesis mechanisms governing the cell 
adhesion and spheroid formation 
Tissue engineering aims not only to create desirable organ substitutes, but also to 
better understand the fundamental mechanisms and principles of biological organization 
in general and morphogenesis in particular [141]. In general, morphogenesis refers to the 
morphological changes during development, which are important in the tissue dynamics 
and in practical aspects of tissue reconstruction, repair and engineering [142]. The 
morphogenesis is a dynamic process usually involving initial conditions, the initiation, 
orderly execution, and completion. The initial conditions refer to the cells and their 
arrangement at the time of initiation, which have a significant impact on the whole 
process. The right cells must be present initially and their approximate relative location 
must be established. To initiate the morphogenic process, there has to be an initiating 
signal to destabilize the initial cellular arrangement and drive the cells to initiate their 
activities. Some of the initial molecular process during morphogenesis is known, 
typically involving changes in the expression of surface protein and alternations in the 
ECM. Following initiation, a dynamic process is executed, which involves the 
coordinated activity of multiple cells and significant physical forces associated with cell 
migration, cell division, and cell differentiation. This spatio-temporal process of 
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morphogenesis should exhibit some self-assembly characteristics, which must be robust 
and be able to converge on the desired and stable final-state. From an engineering 
standpoint, this means that the process intrinsically knows what to do. The engineering 
challenge is trying to mimic the correct in vivo parameters in vitro to ensure that the 
tissue assembly can converge on the final state. The robust self-assembling nature of the 
morphogenic process makes it happen for most cases. After the morphogenesis reaches 
its final state, there is no further morphogenic diving force for cellular activity leading to 
morphogenesis. The final state is then stabilized through processed such as long-term 
ECM modeling during wound healing.  
Hepatocyte spreading or spheroid self-assembly on different substrata involves cell 
translocation and changes in cell shape, mimicking the process of tissue formation. The 
mechanism study of cell spreading and spheroid formation is useful for revealing 
invaluable clues regarding the principles of how cells organize into the structured tissues. 
To predict morphological outcomes for cells morphorgenic dynamics on substrata with 
different ‘adhesive properties’, Martz proposed a model evolved through a 
thermodynamic free energy minimization process. The model predicted that, when cell-
substratum attachment sites are abundant or in other word cell-substratum interaction is 
strong, substratum-free energy is minimized by maximizing the number of cell-
substratum adhesion, resulting in cell spreading and monolayer formation on this 
adhesive substratum; Conversely, when cell-substratum attachment sites are sparse or the 
cell-substratum interaction force is weak, substratum free energy is minimized by 
maximizing the more highly adhesive intercellular adhesions, thus cells stick to each 
other and spheroids form on this less-adhesive substratum [114]. In this sense, the 
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relative strengths of cell-cell vs. cell-substratum adhesive interactions will ultimately 
determine the morphogenesis. When primary hepatocytes are cultured on the ECM-
coated substratum, the bioactive motif of the ECM like RGD ligands induce the 
clustering of integrin in the focal adhesion; the cells are attached onto the substratum. 
The ECM-integrin interaction will induce a series of downstream signaling pathways and 
redistribute the cytoskeleton and will finally make cells to spread which indicates that 
ECM-coated substratum is strongly adhesive. The adhesion force of attachment is 
stronger than the cell-cell adhesion force. Therefore, the hepatocytes attached to the 
ECM-conjugated substratum will keep spreading morphology as a monolayer. When 
primary hepatocytes are cultured on the galactose-conjugated substratum, the ASGPRs 
on the cell membrane are clustered in the sites of the adhesion.  The cells are just tethered 
onto the substratum intermediated by ASGPR-galactose binding indicating the 
galactosylated substratum is weakly adhesive. The interactive forces generated between 
cells are stronger than the tethering forces from ASGPR-galactose binding, therefore, the 
cells tend to support each other and form spheroids, since the gal substratum is weakly 
adhesive, the formed spheroids tend to detach from the substratum after certain time of 
culture. 
 
1.4 Problems with the current hepatocyte in vitro culture model for hepatocyte-
based applications 
 
Despite the rapid emergency of above-mentioned novel hepatocyte in vitro culture 
models such as microfabricated devices, their applications in hepatocyte-based drug 
testing and BLAD still take time before the adaptable operating platforms can be 
optimized and widely used (like the current automation platform for the microplate-based 
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high-throughput drug testing). Currently, hepatocyte 2D monolayer and 3D spheroid are 
still the gold-standard of 2D and 3D hepatocyte in vitro model respectively. Instinctive 
problems of these two models exist which require further improvements. For 2D 
hepatocyte monolayer configuration, the spreading hepatocytes rapidly lose their liver-
specific functions such as albumin secretion, urea synthesis and metabolic/detoxification, 
reflecting dedifferentiation [132]. The dedifferentiation of the spreading 2D cells is likely 
due to their structural and functional difference from hepatocytes in vivo. As for the 3D 
hepatocyte spheroid, its usefulness is limited due to the poor mass transport of nutrients, 
oxygen, xenobiotics and metabolites into and from the core of these large cellular 
aggregates with uncontrollable sizes [111, 112]. In addition, due to the poor adhesion of 
spheroids on the substratum, cell loss is also a critical issue in forming and maintaining 
these spheroids in applications [113].  
 
1.5 Objectives and significance of the current study 
 
The overall aim of the present study was to develop a novel in vitro hepatocyte 
culture model with improved performances compared to the two gold-standards for 
hepatocyte culture, namely the ‘2D hepatocyte monolayer’ and ‘3D hepatocyte spheroid’, 
which can be readily used for hepatocyte-based applications such as drug screening and 
bioartificial liver assisted devices (BLAD). The novel culture model, namely the 3D 
hepatocyte monolayer, exhibits 3D cell characteristics and monolayer structure, which 
takes advantage of the two gold-standards, and eliminates their aforementioned intrinsic 
problems for applications. In order to achieve the overall objective, various milestones 
have been achieved as listed below: 
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I. Fabrication and characterization of GRGDS modified, Galactosylated and Hybrid 
GRGDS/Galactose modified polyethylene terephthalate (PET) film and PET porous 
membrane 
II. Identification and characterization of the 3D hepatocyte monolayer  on the 
galatosylated PET film 
III. Stabilization of the 3D hepatocyte monolayer up to one week cultured on the 
Hybrid GRGDS/Galactose PET film, and its application in hepatocyte-based drug 
hepatotoxicity screening  
IV. Longer-term stabilization of the 3D hepatocyte monolayer in an ‘ECM-free’ 
synthetic sandwich culture, which is constructed by sandwiching a 3D hepatocyte 
monolayer between a GRGDS-modified PET Track-etched membrane (top support) 
and a galactosylated PET film (bottom substratum) 
 
 The novel 3D hepatocyte monolayer stabilized on Hybrid GRGDS/Galactose PET 
film can be readily incorporated into the microplate-based high throughput drug 
screening platform currently used in pharmaceutical industry as a promising alternative 
for conventional 2D hepatocyte monolayer cultured in collagen-coated microplate. The 
3D hepatocyte monolayer culture model may also enable optical microscopy-based 
assays to be easily implemented to assess drug metabolism and hepatotoxicity responses 
directly within living cells. Such advantages could be further exploited to develop high 
content cell-based screening technologies. Therefore, the present study will be of interest 
to pharmaceutical companies and cell-culture-device manufacturers which may find the 
related technologies commercially valuable. Moreover, the novel ‘ECM-free’ synthetic 
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sandwich culture might shed light on a new design of the hepatocyte-based bioreactor 
which would provide a potential prototype for the next-generation of BLAD.  
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Fabrication and characterization of 
Galactosylated, GRGDS-modified and Hybrid 
GRGDS/Galactose modified polyethylene 
terephthalate (PET) film 
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2.1 Introduction  
 
A variety of natural or synthetic polymeric substrata have been employed for 
hepatocytes culture (e.g. plastic surfaces or membranes coated with extracellular matrix 
proteins such as collagen, laminin, fibronectin or conjugated with cell adhesion peptides, 
such as RGD [1] and YIGSR [2]. Hepatocytes anchor tightly to these substrata, and 
exhibit extended and spreading cell morphology, with low levels of liver-specific 
functions likely due to hepatocyte de-differentiation [3]. These substrata have been 
extensively used for xenobiotics screening in microplates [1-3] as well as for BLAD 
bioreactors [1]. 
Galactose conjugated substrata are attractive alternatives for hepatocyte attachment 
through the galactose-asialoglycoprotein receptor (ASGPR) interaction [4]. Several 
strategies have been adopted to fabricate substrata conjugated with galactose ligand [5]. 
Hepatocytes cultured on these galactosylated substrata tend to maintain round cell 
morphology; and self-assemble into 3D spheroids in the presence of epidermal growth 
factor (EGF) [5].  
We have developed here various bioactive substrata by conjugating GRGDS 
peptide and galactose ligand to polyethylene terephthalate (PET) film separately or 
simultaneously. Commercialized PET film was surface-modified with acrylic acid (AAc) 
followed by ligands conjugation (GRGDS peptide and/or galactose ligand) in a ‘two-
step’ ‘EDC’ chemistry. The PET film conjugated with both the GRGDS peptide and 
galactose ligand (PET-Hybrid) was inserted into 96-well microplates for hepatocyte 
culture, with PET film conjugated with only GRGDS peptide (PET-RGD), galactosylated 
PET (PET-Gal) and collagen-coated microplates as controls. Hepatocytes exhibited 
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enhanced attachment after seeding on the bioactive substrata (PET-Gal, PET-Hybrid), 
which were comparable to the attachment on the collagen-coated substratum.  
 




Biaxially-oriented poly(ethylene terephthalate) (PET) films of about 100µm in 
thickness were purchased from Goodfellow Inc. of Cambridge, U.K. The galactose ligand, 
1-O-(6’-aminohexyl)-D-galactopyranoside (AHG, M.W. 279) was synthesized according 
to the method developed previously [3, 6, 7] and verified by NMR spectrum (Fig. 3). 
RGD peptide (GRGDS) was purchased from Peptides International. All other chemicals 
were purchased from Sigma-Aldrich Singapore unless otherwise stated.  
 
Fig. 3 NMR spectrums of galactose ligand AHG. 
 
Fabricating PET film grafted with poly acrylic acid (PET-PAAc) (Fig. 4)  
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Poly-acrylic acid (PAAc) was grafted onto the PET film surface with a modified 
protocol [3, 8] for conjugating bioactive ligands. Briefly, PET film was cut into 2cm x 
8cm strips and cleaned in ethanol. The air-dried PET strips were subject to argon plasma 
treatment which was carried out in SAMCO Basic Plasma Kit (SAMCO International 
INC.) operating at a radio frequency (RF) of 13.6MHz. Argon was introduced into the 
chamber in the SAMCO kit at a flow rate of 50ml/min with chamber pressure maintained 
at 20Pa. Plasma was generated at an electric power of 40W for 1min. After the plasma 
treatment, the PET strips were exposed to atmosphere for 10mins to promote the 
formation of surface peroxides and hydroperoxides, which were used for the subsequent 
UV-induced grafting of PAAc. For the UV-treatment, quartz tubes with length of 12cm 
and diameter of 2.5cm were fabricated at the Glassware workshop of the Department of 
Chemistry at NUS. The plasma-treated PET-strip was immersed in 30ml of the aqueous 
solution containing acrylic acid in the quartz tube. Argon was bubbled through the 
solution to thoroughly remove oxygen. The quartz tube was capped tightly and placed in 
water bath with constant temperature of 28oC and subjected to UV irradiation for 30min 
using a 400W flood lamp in UV-F 400 unit (Panacol-Elosol GmbH). After grafting, the 
PET strip was taken out of the tube and washed extensively with deionized water for 24h 
to remove the residual homopolymer absorbed on the surface.     
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Fig. 4 Schematic diagram of the procedure of grafting PAAc on the PET film upon argon 
plasma activation and UV-induced polymerization.  
 
Fabricating bioactive substrata by conjugating GRGDS and/or Gal ligands onto PET-
PAAc film via ‘two-step’ EDC chemistry (Fig. 5) 
PET-PAAc strips were cut into circular disks with diameter of 6.4mm in order to fit 
into the 96-well microplates. GRGDS peptide and galactose ligand were conjugated via 
amide bonds onto PET-PAAc separately or simultaneously using a ‘two steps’ EDC (1-
Poly-acrylic acid 
grafted PET film 






resultant PET film 
placed in quartz 
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Ethyl-3-[3-dimethylaminopropyl] carbodiimide Hydrochloride) chemistry (Fig. 5). 
Briefly, at the first step, 100µl of MES buffer (50mM, pH of 5.5) containing 1.5mg EDC 
and 0.3mg sulfo-NHS were added to each 96-well containing the PET-PAAc disk to 
activate the surface carboxylic groups by forming NHS esters. After 2h activation at 
room temperature, the MES solution was completely removed and replenished with 
100µl phosphate buffer (0.1M, pH of 7.4) containing ligands and allowed to react with 
activated substratum by shaking at 300rpm in a thermomixer (Eppendorf) for 48h at 4oC. 
PET-RGD or PET-Gal was fabricated by reaction with GRGDS peptide or galactose 
ligand respectively. PET-Hybrid was fabricated by reaction with homogeneous mixture 
of GRGDS peptide and galactose ligand with different ratios. After conjugation of the 
bioactive ligands, each sample was quenched with 0.5% ethanolamine solution for 15min 
to block non-specific interactions of the un-reacted carboxylic groups with the 
hepatocytes. The microplates containing different substrata were sterilized by soaking in 
70% ethanol for 3h and then rinsed 3 times with PBS. Collagen-coated substratum was 
prepared by incubating 100µl of 1.5mg/ml collagen solution into each well of the 96-well 
microplates overnight at 4oC. The excess collagen solution was aspirated and each well 
rinsed 3 times with PBS. 
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Fig. 5 Schematic diagram of ligands conjugation onto PET-PAAc by a 2-step reaction 
scheme (solid arrows) and quantitative analysis of the conjugated ligands by RP-HPLC 
(dotted arrows). 
 
Characterization of PET-RGD, PET-Gal and PET-Hybrid substrata 
• Determination of the Surface-Grafted PAAc concentration 
The density of the graft carboxylic groups on the PET films was determined by a 
colorimetric method using Toluidine Blue O (TBO) staining previously reported [3, 9]. 
• X-ray photoelectron spectroscopy Measurements (XPS) 
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XPS was used to qualitatively verify the PAAc grafting and ligand conjugation onto 
the PET film. Measurements were made on a VG ESCALAB Mk II spectrometer with 
Mg Kα X-ray source (1253.6 e V photons) at a constant retard ratio of 40.  
• RP-HPLC quantification of the conjugated GRGDS peptide and Gal ligand on PET 
GRGDS peptide and/or Gal ligand on PET were hydrolyzed off the substrata using 
Acid Hydrolysis Station (C.A.T. GmbH & Co.) in 6N HCl at 110 oC for 24h under 
vacuum. The cooled hydrolyzed solution was filtered into a new vial and evaporated 
under nitrogen. The hydrolyzed ligands from PET were re-suspended in 50µl DI-water 
and derivatized using ATTO-TAG™ CBQCA Amine-Derivatization Kit (Molecular 
Probes) for fluorescence detection after separation on a reverse phase C-18 column in 
HPLC (Agilent Technology). Optimized operational conditions: Mobile phase: A: Water 
+ 0.1% TFA, B: Acetonitrile + 0.1% TFA; Gradient: A/B (98:2) to (70:30) in 45mins; 
Flow rate: 1ml/min; Fluorescence detection: excitation@450nm, emission@550nm. 
Standard curves were established against hydrolysis product of soluble GRGDS peptide 
and Gal ligand respectively. Among the hydrolysis product of GRGDS peptide, the peak 
corresponding to arginine was chosen to represent and quantify GRGDS peptide due to 
its sharpness and early elution time in the chromatograph.     
 
Hepatocyte isolation and culture 
Hepatocytes were harvested from male Wistar rats weighing 250–300g by a two-
step in situ collagenase perfusion method [10]. Animals were handled according to the 
IACUC protocol approved by the IACUC committee of the National University of 
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Singapore. Viability of the hepatocytes was determined to be >90% by Trypan Blue 
exclusion assay and a yield of >108 cells/rat.  
Freshly isolated rat hepatocytes (3.2×104) were seeded onto different substrata at 
1×105 cells/cm2 within 96-well microplate and cultured in 100µl of William’s E culture 
medium supplemented with 10mM NaHCO3, 1mg/ml BSA, 10ng/ml of EGF, 0.5µg/ml of 
insulin, 5nM dexamethasone, 50ng/ml linoleic acid, 100units/ml penicillin, and 100µg/ml 
streptomycin. Cells were incubated with 5% CO2 at 37°C and 95% humidity. After 2h 
incubation, culture medium containing the unattached cells was removed; the wells were 
rinsed with PBS and replenished with fresh culture medium on a daily basis.  
Hepatocyte attachment on different substrata after 2h was calculated based on a 
DNA analysis method [11]. Attached cells were lysed on the substrata by a freeze-thaw 
cycle of freezing in DNA-free DI-water at -80oC overnight and thawing at 37oC. DNA 
concentration was determined using PicoGreen® dsDNA quantitation kit (Molecular 
Probe). The attached cell number was determined using a standard curve generated from 
the DNA concentrations of known number of cells. Hepatocyte attachment on different 
substrata was expressed as the seeding efficiency (attached cell number divided by total 
cell number initially seeded).  
 
2.3 Results  
 
2.3.1 Fabrication and characterization of PET film grafted with poly-acrylic acid 
 
Poly-acrylic acid (PAAc) was grafted onto the poly (ethylene terephthalate) (PET) 
film by argon-plasma treatment and UV-induced copolymerization. The effectiveness of 
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the grafting was demonstrated by XPS analysis (Fig. 4). The XPS wide scan spectrum of 
the pristine PET film showed peaks corresponding to C 1s (binding energy, 285eV) and 
O 1s (binding energy, 532eV), which revealed the presence of carbon and oxygen signals. 
The spectrum of PET-PAAc film (Fig. 4) showed the same peaks as pristine PET film; 
however, the relative intensity ratio of oxygen to carbon peaks was higher in PET-PAAc 
film than in pristine PET film. The PAAc grafting density was quantified by TBO 
colorimetric assay [3, 9]. PET-PAAc substrata with carboxyl group densities from 
8.2±2.3 to 258.2±24.2nmol/cm2 could be obtained by varying the initial concentration of 
the acrylic acid monomer solution from 1%-5%. As reported previously, the difference in 
density of carboxylic groups and conjugated galactose ligand was not expected to lead to 
significant differences in 3D hepatocyte spheroids formation and functional maintenance 
when the densities were above certain value [3]. 3.75% acrylic acid monomer solution 
was chosen to fabricate PET-PAAc with carboxyl-group density of 78.5±10.2 nmol/cm2 
for the following ligands conjugation and cell culture in order to achieve the desirable 
ligand-conjugation density using the relatively inefficient two-step ‘EDC chemistry’ [12].  
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Fig. 6 XPS wide scanning spectrums of PET, PET-PAAc PET-Gal and PET-RGD which 
showed the successful grafting of poly-acrylic acids and following conjugation of 
GRGDS peptide and galactose ligand onto PET-PAAc. 
 
2.3.2 Fabrication and characterization of bioactive substrata  
 
RGD peptide (GRGDS) and/ or galactose ligand (AHG) were conjugated onto PET-
PAAc (Fig. 1), and successful conjugation of ligands was confirmed by XPS (Fig. 6). In 
contrast to pristine PET and PET-PAAc, a new peak corresponding to N 1s (binding 
energy, 400eV) introduced by bioactive ligands appeared in the spectra of PET-RGD, 
PET-Gal and PET-Hybrid. To measure the amount of the GRGDS and/or AHG 
conjugated onto the films, we removed the conjugated GRGDS and/or AHG from the 
film by acid hydrolysis; and quantified the hydrolyzed GRGDS and AHG by RP-HPLC 
with fluorescence detector after derivatizing the hydrolysis products of GRGDS and 
AHG to fluorescent substances. Representative chromatograms of different samples were 
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illustrated in Fig. 7A. We controlled the ratio of the GRGDS and AHG in PET-Hybrid by 
monitoring the conjugation efficiencies of the GRGDS and AHG onto PET-PAAc 
respectively. GRGDS exhibited higher conjugation efficiency than AHG (Fig. 7B, 7C). 
3mg/ml (0.3mg per 96well) AHG and 0.6mg/ml (0.06mg per 96 well) GRGDS were 
chosen to react with the activated PET-PAAc to achieve a conjugation ratio of ~1:1. The 
final density of the conjugated GRGDS and AHG on the film was 5.63±0.86 nmol/cm2 
and 6.94±0.74 nmol/cm2 respectively. For 78.5±10.2 nmol/cm2 of carboxylic groups 
available on PET-PAAc, ~16% were conjugated with the ligands. To achieve 1:5 and 5:1 
ratios of conjugated GRGDS and AHG, we used 0.12mg/ml and 3mg/ml GRGDS 
respectively to co-conjugate with 3mg/ml AHG onto PET-PAAc. The final densities of 
GRGDS/AHG were 1.31±0.49/5.38±0.89noml/cm2 and 19.40±3.19/4.36±0.45noml/cm2. 
For PET-Gal or PET-RGD, 3mg/ml AHG or 0.6mg/ml GRGDS was reacted with the 
activated PET-PAAc respectively. The density of conjugated AHG of PET-Gal was 
5.92±0.74nmol/cm2 and the density of conjugated GRGDS of PET-RGD was 
7.04±0.96nmol/cm2. 
 
2.3.3 Enhancement of hepatocyte attachment on the bioactive substrata  
 
Ligands conjugation significantly enhanced hepatocyte attachment onto the 
bioactive substrata after 2h of seeding as shown by the DNA content assay (Fig. 8). 
Hepatocytes attached very well to PET-Gal, PET-Hybrid and collagen-coated substratum; 
and attached less well to PET-RGD, and poorly to PET-PAAc and Tissue culture plate 
(TCP). Similar numbers of hepatocytes attached to PET-Hybrid with GRGDS: galactose 
ratios of 1:5, 5:1 or 1:1 (data not shown). 
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Fig. 7 Quantitative analysis of the conjugated GRGDS peptide (GRGDS) and galactose 
ligand (AHG) by RP-HPLC. (A) Representative RP-HPLC Chromatograms of Arginine 
(a), hydrolysis product of soluble GRGDS peptide (b) and soluble galactose ligand (c) as 
standards, and  hydrolysis product of the PET-Hybrid conjugated with GRGDS peptide 
and galactose ligand (d); (B) Conjugation efficiency curve of GRGDS peptide onto PET-
PAAc; (C) Conjugation efficiency curve of galactose ligand onto PET-PAAc. 
 
 
Fig. 8 Hepatocyte attachment onto different substrata 2h after seeding as represented by 
the DNA content measurements. Data are means ± SD, n=10 (*): P<0.05, (**): P<0.01, 
(N.S): not significant 
 
  
2.4 Conclusion and discussion  
 
In this chapter, various bioactive PET films have been fabricated, including GRGD-
modified, galactosylated and Hybrid GRGDS/Galactose PET films. The commercialized 
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plasma activation and UV irradiation. GRGDS peptides and/or galactose ligands were 
conjugated on to the carboxylic acid chains of the PAAc using standard ‘EDC/ Sulfo-
NHS’ chemistry. The successful grafting of PAAc and conjugation of GRGDS and/or 
Galactose were verified by XPS. The density of carboxylic acid groups grafted on the 
PET film was quantified by TBO; and the density of GRGDS and/or galactose ligands 
conjugated on the PET film were quantified by RP-HPLC. Different substrata were cut to 
fit into the 96-well microplate for primary rat hepatocyte culture. The conjugation of 
bioactive ligands (PET-Gal, PET-Hybrid) significantly enhanced the hepatocyte 
attachment on the substratum, which was comparable to the hepatocyte attachment on the 
collagen-coated substratum.  
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3.1 Introduction  
 
Cells dissociated from a variety of tissues such as mammary gland, pancreatic islet, 
lung and liver have the capacity to self-assemble in vitro into multi-cellular aggregates 
resembling the organization and architecture of their tissues in situ [1]. Understanding 
and controlling the morphogenesis of these three dimensional tissue-like multi-cellular 
aggregates is a fundamental objective of tissue engineering research [2]. In liver tissue 
engineering, self-assembled spheroidal aggregates of isolated primary hepatocytes have 
been obtained in suspension culture [3] and on numerous moderately-adhesive substrata 
comprised of natural matrices such as proteoglycan fraction from liver reticulin fibers [4], 
agarose [5], rigid extracellular matrix at low concentration like Matrigel, laminin, 
fibronectin or collagen I [6],  and artificially synthetic matrices such as positively charged 
[7] or galactosylated [8] substrata. Mechanistic studies of spheroid formation on 
positively-charged and rigid extracellular matrix-coated substrata implied that the 
interplay between cellular contraction forces and cell-substratum adhesive forces plays an 
important role in the determination of hepatocyte aggregate morphogenesis [1, 6, 9].  
Hepatocytes spheroids are believed to re-establish in vivo-like 3D architectures and 
associated cell-cell/cell-matrix interactions with enhanced hepatocyte differentiated 
functions,  polarities and liver tissue-structures such as the well-established bile canaliculi, 
tight junctions and gap junctions [10]. These features render the hepatocyte-spheroids 
useful in applications such as bio-artificial liver-assisted devices (BLAD) [11] and drug 
metabolism/hepatotoxicity studies [12, 13]. We and others have developed bioactive 
galactosylated substrata to form rat hepatocyte spheroids by conjugating galactose ligand 
to polymeric materials [14-16] such as polyethylene terephthalate (PET) film. We 
 - 59 -
investigated here the dynamic self-assembly process of the hepatocyte spheroids on the 
galactosylated PET film by live-cell time-lapse confocal imaging and identified 4 distinct 
stages with drastically different cell morphologies, namely 1) small cell-aggregates, 2) 
“island-like” clusters, 3) pre-spheroid monolayer, and 4) 3D spheroids. By analyzing the 
dynamics of F-actin, phosphorylated focal adhesion kinase (p-FAK) and E-Cadherin 
expression during spheroid formation, we tested the hypothesis that the hepatocyte 
spheroid morphogenesis on the galactosylated substratum is heavily influenced by a 
balance between cell-cell and cell-substratum interactions. Hepatocytes in the pre-
spheroid monolayer stage exhibited the strongest cell-substratum interactions with 
comparable cell-cell interactions and F-actin distribution as the 3D spheroids.  We 
characterized  the  hepatocytes in the pre-spheroid monolayer, 3D spheroids and the 
conventional 2D monolayer on collagen substratum in terms of their polarity 
(MRP2)/tight junction (ZO-1) formation, albumin secretion, urea production and 
cytochrome P450 1A activity as well as sensitivity to hepatotoxicity induced by three 
model drugs (Acetaminophen, Aflatoxin B1 and D-galactosamine). Hepatocytes in pre-
spheroid monolayer exhibited better polarity/ tight junction formation, enhanced 
hepatocyte differentiated functions and higher sensitivity to drug-induced hepatotoxicity 
than in conventional 2D monolayer. Due to the 3D characteristics of the cells in pre-
spheroid monolayer, we coin the name ‘3D hepatocyte monolayer’ in order to be 
distinguished from the conventional 2D hepatocyte monolayer.  
The results provide clues to elucidate the mechanisms of spheroids self-assembly on 
galactosylated bioactive substrata which potentially direct the design of more appropriate 
bioactive biomaterials; and the 3D monolayer may be a novel hepatocyte in vitro culture 
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model for liver tissue engineering applications such as BLAD and drug 
metabolism/hepatotoxicity studies. 
 
3.2 Materials and methods 
 
Materials 
Galactosylated polyethylene terephthalate (PET) film (PET-Gal) was fabricated and 
characterized as described in Chapter 2. The modified films were cut into circular disk of 
1.5cm diameter to fit into 24-well microplate or with diameter of 6.4mm to fit into 96-
well microplate (NUNC). Collagen substratum was prepared by physical absorption of 
collagen solution (1.5mg/ml) onto the microplate overnight at 4oC. The excess collagen 
solution was aspirated followed by 3× rinsing with PBS. 
Primary anti-CD147 monoclonal antibody was purchased from Serotec (NC, USA); 
Primary rabbit anti-ZO-1 antibody was purchased from Zymed laboratories (San 
Francisco, USA); Primary rabbit anti-p-FAK antibody was purchased from Upstate 
(Charlottesville, USA); Primary rabbit anti-E-Cadherin antibody was purchased from 
Santa Cruz (CA, USA); Secondary TRITC-conjugated goat anti–rabbit IgG and FITC-
conjugated goat anti–mouse IgG were purchased from Molecular Probes (Invitrogen, 
Singapore); Primary rabbit anti-β-actin and anti-GAPDH antibodies were purchased from 
Abcam (Cambridge, UK); Secondary donkey anti-rabbit IgG Horseradish Peroxidase 
linked antibody was purchase from GE healthcare (Singapore). All other reagents were 
purchased from Sigma-Aldrich Singapore unless otherwise stated.  
 
Hepatocyte isolation and culture 
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Hepatocytes were harvested from male Wistar rats weighing 250–300g by a two-
step in situ collagenase perfusion method [17]. Animals were handled according to the 
IACUC protocol approved by the IACUC committee of the National University of 
Singapore. Viability of the hepatocytes was determined to be >90% by Trypan Blue 
exclusion assay and a yield of >108 cells/rat was obtained.  
Freshly isolated rat hepatocytes (0.2×106) were seeded onto different substrata at 
1×105 cells/cm2 within 24-well microplate and cultured in 1ml of William’s E culture 
medium supplemented with 1mg/ml BSA, 10ng/ml of EGF, 0.5µg/ml of insulin, 5nM 
dexamethasone, 50ng/ml linoleic acid, 100units/ml penicillin, and 100µg/ml 
streptomycin. Cells were incubated with 5% CO2 at 37°C and 95% humidity. After 2h 
incubation, culture medium containing the unattached cells was removed; the wells were 
rinsed with PBS and replenished with fresh culture medium on a daily basis during the 
entire culture period. 
 
Live-cell time-lapse confocal imaging 
The ‘Galactosylated-bottom’ culture dish was self-made by using WillCo-dish Kit 
(WillCo Wells B.V., Netherland). A PET-Gal film disk with diameter of 1.2cm was glued 
onto the bottom of the 35mm Willco dish. Hepatocytes were seeded onto the 
galactosylated-bottom dish at the density of 1×105 cells/cm2 and cultured in a live 
imaging chamber with temperature and CO2 control (PeCon, Germany). Transmission 
images of hepatocyte morphology were captured at 5min intervals using 10× objective on 
a Zeiss LSM510-Meta confocal microscope for up to 3d. The dynamic change of cell 
morphology was quantified by using the count/size functions of the Image-Pro Plus 
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software (MediaCybernetics, USA) as a ratio of the substratum area covered by the 
hepatocytes at a particular time point normalized with the substratum area covered by the 
post-seeding hepatocytes at 0h; and expressed as substratum coverage. 
 
Immunofluorescence microscopy 
For F-actin staining, the cells were fixed using 3.7% paraformaldehyde (PFA); 
blocked in 10% fetal calf serum (FCS) at room temperature for 1h; permeabilized for 
5min in 0.1% Trion X-100 and 1% bovine serum albumin (BSA); incubated with TRITC-
phalloidin (1µg/ml) for 20min and then rinsed 3× with PBS before imaging. For double-
staining of MRP2/CD147 and ZO-1/CD147, cells fixed with PFA were blocked with 
10% FCS at room temperature for 1h. Samples were incubated with the primary 
antibodies (1:10) overnight at 4oC. After rinsing 3× with PBS, the samples were 
incubated with the secondary antibodies (1:200, TRITC-conjugated goat anti–rabbit IgG; 
FITC-conjugated goat anti–mouse IgG) at room temperature for 1h and rinsed 3× with 
PBS before being mounted in FluorSaveTM (Calbiochem, CA). The samples were imaged 
with a Fluoview-300 confocal microscope (Olympus, Japan) with 63× water-immersion 
objective (NA1.2).  
Quantification of the Mrp2 or ZO-1 localization along the cell boundaries 
(basolateral CD147) was performed by implementing an image processing algorithm 
developed in Visual C++ 6.0: The green pixels in each image from the CD147 staining 
were first binarized by thresholding segmentation to yield cell boundaries with one-pixel 
thickness; the red pixels in the same image from the Mrp2 or ZO-1 staining were 
binarized to yield the regions that contain a significant concentration of the respective 
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marker; and the total number of red pixels in the image was calculated as Itotal. For each 
red pixel, the distance to the closest cell boundary pixel was obtained from a distance 
map [18]. Extra-cellular red pixels residing in the bile canaliculi-like structures were 
identified and differentiated from the intra-cellular red pixels by using the ‘region 
growing’ algorithm [19]. Intra-cellular red pixels within 2-pixel distance from the closest 
boundary pixel and extracellular red pixels were counted as Ilocalized. The ratio between 
Ilocalzied and Itotal was used to describe the localization of Mrp2 or ZO-1 along the cell 
boundary.  
Scanning electron microscopy 
3.7% PFA-fixed samples were rinsed in PBS and then post-fixed with osmium 
tetraoxide for 1h. Dehydration was accomplished using a graded series of ethanol (25%, 
50%, 75%, 95%, and 100%). The samples were then critical-point dried for 2h in 
absolute alcohol, mounted onto a brass stub and sputter-coated with platinum (JFC-1600, 
JEOL), before being viewed under a field-emission scanning electron microscope (JSM-
7400F, JEOL). 
Quantification of p-FAK  expression by ELISA 
ELISA of p-FAK was performed according to the protocol of FACETM p-FAK 
ELISA kit (Active Motif, Inc., USA); Briefly, hepatocytes cultured on different substrata 
in 96-well plate after designated culture periods were fixed with 3.7% PFA for 20min at 
room temperature. After blocking with 1% BSA for 1h at room temperature, the cells 
were incubated with 1:400 diluted anti-p-FAK primary antibody overnight at 4oC. The 
cells were rinsed 3× with PBS and incubated with diluted anti-rabbit IgM-HRP 
(horseradish peroxidase) secondary antibody (1:2500) for 1h at room temperature. Cells 
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staining with only secondary antibody were used for background subtraction. After 3× 
rinsing with PBS, the HRP activity was colorimetrically measured by developing with  
substrate solution (Tetramethyl benzidine, BETHYL Laboratories, Texas, U.S.A). 
Absorption was measured in a microplate reader (Tecan Safire2, Switzerland) at 450nm 
and normalized to the total cells seeded initially (32,000cells/well).  
 
Western blot  
Cultured hepatocytes were lysed with RIPA buffer (50mm Tris-HCL, 150mM NaCl, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease inhibitor 
cocktail (Roche, Singapore) for 30min at 4oC. Lysates then were clarified by 
centrifugation at 10,000g for 20 min at 4oC. The protein concentration per sample was 
quantified by Dc protein Reagent assay (Bio-rad, U.S) which was diluted in sample 
loading buffer (2% SDS, 80mM Tris-HCl, 10% glycerol, 0.1% Bromophenol blue, 5% 2-
mercaptoethanol) and heated for 5 min at 95oC. 10µg protein sample per lane was loaded 
and fractionated by 7.5% SDS-PAGE gel and transferred to a PVDF membrane 
(Millipore, U.S) by semi-dry electro-blotting. The membranes were blocked with 5% 
non-fat milk in TBS-T for 1h at room temperature and incubated with primary rabbit anti-
E-Cadherin or anti-β-actin or anti-GAPDH (1:1000 diluted in TBS-T buffer) overnight at 
4oC. After 3× washing with TBS-T buffer, the membrane was incubated with secondary 
donkey peroxidase-conjugated anti-rabbit IgG 1:10,000 diluted in 2.5% non-fat milk for 
1h at room temperature. After 4× washing with TBS-T buffer, the membrane was treated 
with Amersham ELC plus reagent (GE Healthcare, UK) ; and light emission was detected 
by exposing the membrane to a Hyperfilm (GE Healthcare, UK).Films were developed 
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by using a KODAK Medical X-ray Processor (KODAK, USA) and imaged by using a 
KODAK IMAGE Station 2000MM (KODAK, USA).  
 
Hepatocyte functional assays 
All functional data were normalized to 106 cells. Cell number was calculated based 
on the total DNA amount quantified by the Pico-green DNA quantification kit 
(Invitrogen, Singapore). The daily albumin production was measured with the Rat 
Albumin ELISA Quantitation Kit (Bethyl Laboratories, Texas ,USA). The urea secretion 
of the hepatocyte cultures incubated in culture medium with 2mM NH4Cl for 90min was 
measured with the Urea Nitrogen Kit (Stanbio Laboratory, Texas, USA). The 7-
ethoxyresorufin-O-deethylation (EROD) assay [20], which measures the de-ethylation 
activity of cytochrome P450 (CYP) 1A-associated monooxygenase enzymes, was 
initiated by incubating the cells with culture medium containing 39.2µM 7-
ethoxyresorufin at 37 ºC for 4h. The amount of resorufin converted by the enzymes was 
calculated by measuring the resorufin fluorescence in the incubation medium at 530nm 




 The hepatotoxicity testing with acetaminophen (APAP), Aflatoxin B1 or D-
Galactosamine was performed in 96-well microplates as previously described [14, 21, 22]. 
Briefly, hepatocytes were seeded and cultured on collagen-coated microplate or PET-Gal 
disks fit into the 96-well microplate. The drugs were dissolved in DMSO such that the 
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final concentration of DMSO in the medium was less than 0.2% at every drug 
concentration. 3D hepatocyte monolayer cultured on PET-Gal at day 2 and conventional 
hepatocytes cultured on collagen substratum at day 2 were exposed to the drugs with 
various concentrations for 24h until cell viability was measured.  
MTS assay using the CellTiter 96 Aqueous One Solution Reagent (Promega, 
Singapore) was conducted to quantify cell viability. After treatment with drugs, cells 
were exposed to 100µl/well of 5× diluted MTS reagent in phenol-red-free William’s E 
culture medium and incubated for 3h at 37oC. The absorption of MTS was measured at 
450nm using microplate reader (Tecan Safire2, Switzerland). The response to drugs from 
the hepatocytes cultured on different substrata was expressed as the ‘survival ratio’, 
which was calculated by the MTS assay reading on hepatocytes exposed to drugs 




Data from three independent experiments were analyzed and values were 
represented as mean±standard error of means. The Student t-test was used to analyze the 






3.3.1    Identification of a 3D hepatocyte monolayer formed on a galactosylated PET 
film by live-imaging study of the dynamic hepatocyte morphogenesis 
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Primary rat hepatocytes were seeded onto the ‘Galactosylated-bottom’ Willco dish 
at a density of 105cells/cm2 for live-cell time-lapse confocal imaging (see supplementary 
video and Fig. 9). During hepatocyte self-assembly, dramatic changes occurred in cell 
morphology and substratum coverage (Fig. 9). Hepatocytes on galactosylated substratum 
(PET-Gal) underwent 2 cycles of cell-aggregation to form mature 3D spheroids. Single 
hepatocytes seeded on PET-Gal first aggregated (indicated by reduced substratum 
coverage) in 12h into small cell-aggregates with only several hepatocytes per aggregate. 
These aggregates moved around and merged to form larger aggregates which were 
gradually stretched into ‘island-like’ clusters at around 1d. The ‘island-like’ clusters 
spread to form pre-spheroid monolayer in 2d exhibiting the maximum substratum 
coverage.  The pre-spheroid monolayer folded into multilayer structures and compacted 
into mature and larger 3D spheroids after 3d, which finally detached from the substratum. 
This multi-staged spheroid formation on PET-Gal was quite different from 2D hepatocyte 
monolayer formation on the collagen substratum when hepatocytes gradually spread into 
flattened 2D monolayer (video not shown). We then compared the cytoskeleton 
organization and cell-substratum/cell-cell interactions during 3D spheroid and 2D 
monolayer formation to better understand the mechanisms of hepatocyte-spheroid 
morphogenesis on different substrata.   
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Fig. 9 Morphology of hepatocytes cultured on galactosylated substratum at different 
stages during 3D spheroid formation as characterized by (A) phase-contrast confocal 
microscopy and calculations of the substratum coverage by the cells over time; and (B) 
scanning electron microscopy (SEM) images. 
 
 
3.3.2 Characterization of the pre-spheroid 3D hepatocyte monolayer 
• Cytoskeleton reorganization 
The cytoskeleton is important in regulating cell shape, spreading and migration; and 
is an important determinant of hepatocyte polarity and functions [23, 24]. We examined 
the dynamic organization of actin filaments (F-actin) in hepatocytes during the 3D 
spheroid self-assembly on PET-Gal, and the 2D monolayer formation on collagen 
substratum respectively. F-actin underwent significant rearrangement during the multi-
staged 3D hepatocyte spheroid formation as shown by the fluorescent confocal images 
(Fig. 10): F-actin in the small cell-aggregates at 12h after seeding localized to the cell-
cell contact regions, indicating the establishment of cell-cell interactions. When the small 
cell-aggregates merged into the ‘island-like’ clusters at 1d, actin stress fibers were 
observed throughout the cell-substratum contact region and gradually re-localized back to 
the cell-cell contact region in a cortical distribution as the clusters spread and formed the 
pre-spheroid monolayer. Actin stress fibers in the pre-spheroid monolayer were 
significantly reduced which could be only observed in the cells at the edge. The cortical 
distribution of F-actin was also observed in mature 3D spheroids indicating 3D cell 
characteristic of hepatocytes in the pre-spheroid monolayer. In contrast, F-actin stress 
fibers gradually formed which became more and more intense throughout the cell-
substratum contact region during the 2D monolayer formation on collagen substratum 
(Fig. 10). The expression of β-actin was both gradually up-regulated during 3D 
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hepatocyte spheroid formation and 2D hepatocyte monolayer formation as shown by 
Western blot (Fig. 11B). The up-regulation of β-actin was especially dramatic during 2D 
hepatocyte monolayer formation which may accompany the formation of the abundant 
actin stress fibers.   
 
Fig. 10 F-Actin distribution at various time points during 3D spheroid formation on 
galatosylated PET substratum (upper panel) and 2D monolayer formation on collagen 
substratum (lower panel). 
 
• Cell-substratum and Cell-cell interactions 
The actin cytoskeleton is linked via integrin to focal adhesion complexes to mediate 
cell-substratum interactions [25], and via α, β, γ catenin to E-Cadherin to mediate cell-
cell interactions [26]. Therefore, the organization of the cytoskeleton may reflect the 
relative strength of the cell-substratum and cell-cell interactions experienced by 
hepatocytes [1, 23]. Focal adhesion kinase is a key protein involved in modulating 
assembly of focal adhesions in response to force exerted by the cytoskeleton on 
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attachments to the substratum via integrin. Integrin-mediated adhesion of cells to the 
ECM triggers auto-phosphorylation at the Tyr-397 residue of FAK so that the expression 
of p-FAK is an indicator of cell-substratum interactions. As the main cellular adhesion 
protein to mediate cell-cell interactions, E-Cadherin expression is an indicator of cell-cell 
interactions. We investigated the dynamic changes of cell-substratum and cell-cell 
interactions by analyzing the expressions of p-FAK by ELISA and E-Cadherin by 
western blot during the formation of 3D spheroids on PET-Gal and 2D monolayer on 
collagen substratum. During 3D spheroid self-assembly, p-FAK expression level initially 
increased as the formation of the pre-spheroid monolayer and then dropped as the 
formation of 3D spheroids (Fig. 11A) which is consistent with observations that 3D 
spheroids typically detach from substrata after extended culture [14, 16]. The Pre-
spheroid monolayer exhibited the highest level of the p-FAK expression suggesting the 
strongest cell-substratum interactions among all 4 stages. The phosphorylation of FAK of 
hepatocytes on galactosylated substratum is likely induced by the ECM proteins 
deposited by hepatocytes during culture in vitro (23).  On collagen substratum, a 
continued increase of p-FAK expression was observed during the 2D monolayer 
formation eventually leading to very strong cell-substratum interactions.  
E-Cadherin was highly expressed in hepatocytes at all 4 stages on PET-Gal with 
slight up-regulation in the pre-spheroid monolayer and 3D spheroids (Fig. 11B) 
indicating strong cell-cell interactions; While the expression of E-Cadherin in 
hepatocytes cultured on collagen substratum was initially rare and significantly up-
regulated during 2D hepatocyte monolayer formation (Fig. 11B) indicating gradually 
enhanced cell-cell interactions. The observation of cytoskeleton organization and p-






Fig. 11  p-FAK (indicator of cell-substratum interactions), E-Cadherin (indicator of cell-
cell interactions) and β-actin (cytoskeleton) expression during 3D spheroid formation on 
galactosylated PET substratum and 2D monolayer formation on collagen substratum.(A) 
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p-FAK expression quantified by ELISA (B) Western blot analysis of E-Cadherin and β-




Fig. 12  p-FAK/E-Cadherin double staining of conventional 2D monolayer, pre-spheroid 
3D monolayer, 3D spheroid.  
 
expression results showed that among four stages during hepatocyte spheroid formation, 
the hepatocyte pre-spheroid monolayer exhibited similar F-actin distribution and cell-cell 
interactions as 3D spheroids, with the strongest cell-substratum interactions among all 4 
stages during 3D spheroid formation. p-FAK/E-Cadherin double-staining confocal 
images showed that E-Cadherin localize at the lateral borders of pre-spheroid 3D 
monolayer and 3D spheroids which is much less in 2D monolayer. P-FAK clusters are 
obviously observed in 2D monolayer and less in pre-spheroid 3D monolayer but cannot 
be seen in 3D spheroids (Fig. 12). 
The above findings made the pre-spheroid monolayer an attractive in vitro 
hepatocyte culture model for hepatocyte-based applications. We coined the name ‘3D 
hepatocyte monolayer’ for this novel culture model to be distinguished form the 
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conventional 2D hepatocyte monolayer. We therefore further characterized the 
differentiated functions and structural features of this novel 3D hepatocyte monolayer.  
 
• Differentiated functions and structural features of the 3D hepatocyte  monolayer, 
the 3D spheroids and the 2D monolayer  
 
To evaluate the application potential of this novel 3D hepatocyte monolayer, we 
compared the representative hepatocyte differentiated functions (synthetic, detoxifying 
and metabolic activities) of hepatocytes cultured as 2D monolayer, 3D monolayer and 3D 
spheroids (Fig. 13). The albumin secretion and 7-ethoxyresorufin-O-deethylation 
cytochrome P450 activity of hepatocytes in the 3D monolayer were significantly higher 
than that of the 2D monolayer and comparable to that of the 3D spheroids. Urea synthesis 
exhibited no significant difference among the three configurations.  
 
Fig. 13 Differentiated functions of hepatocytes in 2D monolayer, 3D monolayer, and 3D 
spheroid are measured by (A) albumin secretion, (B) urea production, and (C) 7-
ethoxyresorufin-O-deethylase (EROD) cytochrome P450 activity. (*: P<0.05, **: P<0.01) 
 
The hepatocyte polarity and tight junction formation are key structural features 
necessary to reconstitute important functions such as excretion; and thus are good 
indicators to predict the abilities of these in vitro configurations to mimic the in vivo 
situation [20]. Study of the polarity formation was undertaken with the multidrug 
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resistance-associated protein (Mrp2, the bile canalicular transporter), and the basolateral 
CD147 as apical and basolateral markers respectively (Fig. 14A). Confocal images were 
processed to quantify the co-localization of these two markers. Random distribution of 
Mrp2 throughout the cellular cytoplasm was observed in the 2D monolayer on collagen 
substratum; while in the 3D hepatocyte  monolayer, Mrp2 have localized to the cell-cell 
contact regions indicating polarity formation [20]. In the 3D spheroids, polarity was 
highly established with Mrp2 filling up the bile canaliculi-like structures between 
multiple contacted cells. Tight junction staining with the tight-junction protein ZO-1 and 
the basolateral marker CD147 showed the same trend (Fig. 14B). In 3D hepatocyte  
monolayer, the tight junction protein ZO-1 became concentrated in localized regions 
along cell-cell contacts; whereas in conventional 2D monolayer, ZO-1 was relatively 
diffused throughout the cytoplasm. 
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Fig. 14 The polarity and tight junction formation of hepatocytes in 2D monolayer, 3D 
hepatocyte monolayer, 3D spheroid are quantified by (A) confocal double-staining 
immuno-fluorescence imaging of bile canalicular transporter MRP2 and basolateral 
marker CD143 and (B) tight junction protein ZO-1 and basolateral marker CD143. The 
images were processed and the number in the corner of each processed image is a 
quantitative measure of the Mrp2 or ZO-1 localization along the cell boundaries as 
polarity marker, by an algorithm described in the materials and methods.  
 
3.3.3 Potential application of the 3D hepatocyte monolayer in cell-based hepatotoxicity 
testing of model drugs 
 
Acetaminophen (APAP), a commonly used analgesic, is known to cause 
hepatotoxicity when ingested in large quantities in both animals and man [27]. 
Hepatotoxicity stems from APAP biotransformation by cytochrome P450 (P450) 
enzymes to a toxic intermediate, which can bind to tissue macromolecules, there by 
initiating cellular necrosis. CYP1A, CYP2E and CYP3A are the most active isoforms that 
are able to metabolize APAP [28]. Aflatoxin B1 is another model compound for 
developing toxicity assays since this compound is toxic to cells at nanomolar doses [21]. 
Aflatoxin B1 causes acute hepatotoxicity and liver carcinomas in humans and laboratory 
animals. It is normally oxidized by CYP2C11 and 3A2 to form an intermediate reactive 
epoxide, which binds to cellular macromolecules and causes injury to periportal regions 
of the liver [29]. D-galactosamine is known for inducing the features of acute hepatitis in 
rats [30]. The toxic effect of D-galactosamine is connected with an insufficiency of UDP-
glucose and UDP-galactose and the loss of intracellular calcium homeostasis. These 
changes affect cell membranes and organelles and the synthesis of proteins and nucleic 
acids. After D-galactosamine application, the location of proteoglycans is changed in the 
rat liver. D-galactosamine also inhibits the energy metabolism of hepatocytes. 
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Responses to hepatotoxicity caused by APAP, Aflatoxin B1 or D-galactosamine to 
the 3D hepatocyte monolayer and the 2D monolayer were investigated. In drug-free 
condition, hepatocytes in all culture configurations showed similar basal level of viability. 
In all drug dosage conditions, the 3D hepatocyte monolayer exhibited higher sensitivity 
(or lower survival ratio) to the APAP, Aflatoxin B1 or D-galactosamine-induced 
hepatotoxicity than the 2D monolayer (Fig. 15). The higher sensitivity to APAP, 
Aflatoxin B1 or D-galactosamine-induced hepatotoxicity was also seen in 3D spheroids 
compared with 2D monolayer (data not shown) [14] ,indicating the spheroid-mimic drug 
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Fig. 15 Hepatotoxic sensitivity induced by (A) acetaminophen and (B) Aflatoxin B1 (C) 




3.4    Conclusion and discussion 
 
3D hepatocyte spheroids mimicking the structural and functional characteristics of 
hepatocytes in vivo were self-assembled onto a galactosylated polyethylene terephthalate 
(PET) substratum; and the dynamic process of spheroid formation was investigated by 
time-lapse confocal microscopy. Hepatocytes cultured on this galactosylated substratum 
1) formed small cell-aggregates within 12 hours, which gradually 2) merged into ‘island-
like’ clusters at around 1 day; 3) spread to form pre-spheroid monolayer within 2 days; 
and the pre-spheroid monolayer was stretched to 4) fold into compact and larger 3D 
spheroids after 3 days. We characterized the expressions of F-actin (cytoskeleton), 
phosphorylated Focal Adhesion Kinase (p-FAK, cell-substratum interactions) and E-
Cadherin (cell-cell interactions) during the dynamic process of 3D hepatocyte spheroid 
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formation in comparison with the dynamic process of 2D hepatocyte monolayer 
formation on collagen substratum. Hepatocytes in the pre-spheroid monolayer stage 
exhibited the strongest cell-substratum interactions among all 4 stages during spheroid 
formation with comparable cell-cell interactions and F-actin distribution as the 3D 
hepatocyte spheroids. The pre-spheroid monolayer also exhibited better hepatocyte 
polarity (MRP2)/tight junction (ZO-1) formation, enhanced hepatocyte differentiated 
functions (albumin production and cytochrome P450 1A activity) and higher sensitivity 
to hepatotoxicity than the conventional 2D hepatocyte monolayer.  
We have investigated the dynamic process of hepatocyte self-assembly on a 
synthetic galactosylated PET substratum. Multi-staged hepatocyte spheroid self-assembly 
observed via live-cell confocal imaging involved changes in cell morphology and cell 
translocation which mimics the process of tissue formation [2, 31]. From a biophysical 
point of view, the morphogenesis of hepatocytes cultured on different substrata could be 
ultimately regulated by the relative strengths of cell-cell vs. cell-substratum adhesive 
interactions [32]. As indicated by the p-FAK/E-Cadherin expression analysis, cell-cell 
interactions of hepatocytes cultured on PET-Gal are quite strong throughout the entire 
process of 3D spheroid self-assembly especially in the pre-spheroid monolayer and 3D 
spheroid stages. While the cell-substratum interactions are initially weak due to the weak 
ligand-receptor interactions of galactose and ASGPR [33], then gradually increase with 
the maximum in the pre-spheroid monolayer stage and finally drop as 3D spheroids form. 
Thus it may be reasonable to speculate that when hepatocytes are initially seeded on the 
PET-Gal, the cell-cell interactions are more significant than the cell-substratum 
interactions which induce the migration and aggregation of the hepatocytes; as the cell-
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substratum interactions gradually increase during culture, the balance of cell-cell and 
cell-substratum interactions is reversed resulting in cell spreading and the formation of 
the pre-spheroid monolayer; finally, when the cell-cell interactions again become more 
significant than the cell-substratum interactions, the pre-spheroid monolayer are folded 
and the 3D spheroids are formed. The incorporation of adhesive GRGDS peptide in the 
galactosylated substratum enhances the cell-substratum interactions by interacting with 
integrin membrane receptors thus stabilizing the pre-spheroid monolayer without the 
further formation of 3D spheroids. For the 2D hepatocyte monolayer formation on 
collagen substratum, it may be a relatively simpler scenario: due to the strong ligand-
receptor interactions between collagen/RGD and integrin, the cell-substratum interactions 
dominate the cell-cell interactions throughout the entire process of the 2D monolayer 
formation; thus the cells are gradually spread and flattened with extensive F-actin stress-
fiber formation. Our results demonstrate that the multi-cellular morphogenesis is 
intimately coupled to the dynamic reorganization of the actin cytoskeleton through 
integrin-mediated cell adhesion and E-Cadherin-mediated cell-cell interactions. The 
distributions and expressions of cytoskeleton proteins are also greatly influenced by 
different bioactive substrata.  
The novel 3D hepatocyte monolayer has been characterized with improved cell-
substratum interactions without mass transfer problem compared with 3D spheroids, and 
with enhanced cell-cell interactions, polarity and hepatocyte differentiated functions 
compared with the conventional 2D monolayer; and thus constitute an alternative for 
hepatocyte in vitro culture models. Besides the above-mentioned biophysical regulation 
by cell-substratum and cell-cell interactions, the improved structural and functional 
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properties of the pre-spheroid configuration might be partially caused by biochemical 
responses induced by the galactose-ASGPR interaction. Since there is little knowledge on 
the ASGPR-mediated signaling pathway up to now, elucidation of the active role played 
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4.1  Introduction  
 
In the previous chapter, we have identified a pre-spheroid 3D monolayer stage 
before the 3D hepatocyte spheroid formation on the galactosylated PET film. The 3D 
hepatocyte monolayer has been characterized with relatively strong cell-substratum 
interactions, enhanced cell-cell interactions, improved polarity and liver-specific 
functions than the conventional 2D monolayer which shows great characteristics for 
applications. However, the 3D hepatocyte monolayer is just a transient stage existing 
between 1 day after cell seeding and 3 day before the 3D spheroid formation.  In this 
chapter, we stabilized this attractive 3D hepatocyte monolayer using a Hybrid 
GRGDS/Galactose substratum, which were able to maintain this 3D monolayer stage up 
to one week. With its chemical and mechanical stability and quantitatively controllable 
bioactive cues, the transparent hybrid polymeric substratum is easily and readily 
incorporated into the current microplate-based automation platform for high-throughput 
drug metabolism/hepatotoxicity screening as an alternative for collagen-coated 
substratum. Primary hepatocytes adhere effectively onto the transparent hybrid 
substratum in 96-well plates as monolayer while exhibiting high levels of hepatocyte 
functions, morphology and cell-cell interactions reminiscent of the cells in 3D spheroids. 
As exemplary drug hepatotoxicity study indicated, the 3D hepatocyte monolayer 
configuration provided improved in vitro prediction of the xenobiotics pharmaco-
kinetics/dynamics data that better recapitulate the in vivo biological responses. The 
monolayer of hepatocytes exhibiting the 3D cell behaviors on this flat hybrid substratum 
is compatible with any existing 2D cell culture platform well-established for high 
throughput xenobiotics screening or other applications.  
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4.2 Materials and methods  
 
Materials 
Galactosylated and hybrid Galactose/GRGDS modified polyethylene terephthalate 
(PET) films (PET-Gal and PET-Hybrid) were fabricated and characterized as described 
in Chapter 2. The modified films were cut into circular disk with diameter of 6.4mm to fit 
into 96-well microplate (NUNC). Collagen substratum was prepared by physical 
absorption of collagen solution (1.5mg/ml) onto the microplate overnight at 4oC. The 
excess collagen solution was aspirated followed by 3× rinsing with PBS. All other 
chemicals were purchased from Sigma-Aldrich Singapore unless otherwise stated.  
 
Hepatocyte isolation and culture 
Hepatocytes were harvested from male Wistar rats weighing 250–300g by a two-
step in situ collagenase perfusion method [1]. Animals were handled according to the 
IACUC protocol approved by the IACUC committee of the National University of 
Singapore. Viability of the hepatocytes was determined to be >90% by Trypan Blue 
exclusion assay and a yield of >108 cells/rat.  
Freshly isolated rat hepatocytes (3.2×104) were seeded onto different substrata at 
1×105 cells/cm2 within 96-well microplate and cultured in 100µl of William’s E culture 
medium supplemented with 10mM NaHCO3, 1mg/ml BSA, 10ng/ml of EGF, 0.5µg/ml of 
insulin, 5nM dexamethasone, 50ng/ml linoleic acid, 100units/ml penicillin, and 100µg/ml 
streptomycin. Cells were incubated with 5% CO2 at 37°C and 95% humidity. After 2h 
incubation, culture medium containing the unattached cells was removed; the wells were 
rinsed with PBS and replenished with fresh culture medium on a daily basis.  
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Hepatocyte attachment on different substrata after 2h was calculated based on a 
DNA analysis method [2]. Attached cells were lysed on the substrata by a freeze-thaw 
cycle of freezing in DNA-free DI-water at -80oC overnight and thawing at 37oC. DNA 
concentration was determined using PicoGreen® dsDNA quantitation kit (Molecular 
Probe). The attached cell number was determined using a standard curve generated from 
the DNA concentrations of known number of cells. Hepatocyte attachment on different 
substrata was expressed as the seeding efficiency (attached cell number divided by total 
cell number initially seeded).  
 
Immuno-fluorescence microscopy 
For F-actin, phosphorylated-FAK (p-FAK), and E-Cadherin staining, hepatocytes 
cultured for 3 days on different substrata were fixed in 3.7% Para-formaldehyde (PFA). 
For staining F-actin, the cells were permeabilized for 5min in 0.1% Trion X-100 plus 1% 
bovine serum albumin (BSA) and incubated with TRITC-phalloidin (1µg/ml) for 20min. 
For staining p-FAK, the permeabilized cells were blocked with 1% BSA for 1h and 
incubated for 1h in 25µg/ml of polyclonal antibody of p-FAK (Upstate) and subsequently 
incubated for 1h with TRITC-conjugated goat-anti-rabbit secondary antibody. For 
staining E-Cadherin, fixed cells were blocked with 1% BSA for 1h and incubated with 
10µg/ml E-Cadherin monoclonal antibody for 3h followed by incubation for 1h with 
TRITC-conjugated rabbit anti-mouse secondary antibody. 3D stack of confocal 
microscopy images were acquired with 63X NA1.4 oil lens on a Zeiss Meta 510 
Confocal Microscope. The image stack was reconstructed in a 3D projection with 
maximum intensity projection algorithm (Zeiss LSM 510). 
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Hepatocyte functions 
Total DNA content per sample measured by the PicoGreen DNA assay was used to 
normalize the function data to account for the cell loss from different substrata 
throughout the 7-day culture [3, 4].  
Albumin secretion and urea synthesis  
The albumin secretion by hepatocytes on days 1, 3, 5 and 7 were measured using 
the Rat Albumin ELISA Quantitation Kit (Bethyl Laboratories Inc., Montgomery, Texas). 
Urea synthesis by hepatocytes cultured in phenol-red-free William’s E culture medium 
with 2mM NH4Cl for 90min were measured on days 1, 3, 5 and 7 using the Urea 
Nitrogen Kit (Stanbio Laboratory, Boerne, Texas).  
Induction and measurement of cytochrome P-450 1A activity  
Cytochrome P-450 1A1/2 activity was induced by adding 3-methylcholanthrene 
(3MC) and measured by 7-ethoxyresorufin-O-deethylation (EROD) assay. Briefly, 2µM 
of 3MC was added to the hepatocyte culture medium 24h before measuring the EROD 
activity. On days 1, 3, 5 and 7, hepatocytes induced by 3MC were incubated with phenol-
red-free culture medium containing 8µM 7-ethoxyresorufin (7ER) substrate and 80µM 
dicumarol. Dicumarol was added to prevent degradation of the fluorescent resorufin 
product by cystolic oxidoreductases. After 1h incubation, the 7ER-containing medium 
was collected and measured at 530nm excitation/585nm emission against resorufin 
standards using the microplate reader (Tecan Safire2). 
 
Acetaminophen-induced hepatotoxicity to hepatocytes  
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The hepatotoxicity testing of acetaminophen was modified from procedures 
previously reported [5, 6]. Acetaminophen (APAP) was dissolved in DMSO and the final 
concentration of DMSO in the medium was kept at less than 0.2%. After pre-incubation 
for 24h, hepatocytes cultured on PET-Gal, PET-Hybrid and collagen substratum in 96-
well microplates were exposed to APAP (100µl/well) with high (10mM) and low 
concentration (2mM) respectively for 24h or 48h until cell viability was measured. 2µM 
of 3MC was co-administered with APAP in the drug-drug interaction study. MTS assay 
using the CellTiter 96 Aqueous One Solution Reagent (Promega) was conducted to 
quantify cell viability. After treatment with test drugs, cells were exposed to 100µl/well 
of 5X diluted MTS reagent in phenol-red-free William’s E culture medium and incubated 
for 3h at 37oC. The absorption of MTS was measured at 450nm using microplate reader 
(Tecan Safire2). The response to the test drugs from the hepatocytes cultured on different 
substrata was expressed as the ‘survival ratio’, which was calculated by the MTS assay 
reading on hepatocytes exposed to drugs normalized to the MTS assay reading on drug-
free control. 
 
Treatment of cultured hepatocytes with soluble GRGDS peptide or galactose ligand 
Hepatocytes cultured for 4d as the 3D spheroids on PET-Gal, the 3D monolayer on 
PET-Hybrid and the 2D monolayer on collagen substratum were treated with 100µM 
soluble GRGDS peptide or 200µM soluble galactose ligand (AHG) in culture medium for 
24h. Transmission images of hepatocytes were imaged with phase-contrast optics 
(Olympus IX71, Japan) with 10 × objectives.  
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Statistical methods 
 
Data from three independent experiments were analyzed and values were 
represented as mean±standard error of means. The Student t-test was used to analyze the 
statistical significance of the data. Values with a p value less than 0.05 were considered 
statistically significant. 
 
4.3      Results 
 
 
4.3.1 Stabilization of  the 3D hepatocyte monolayer using Hybrid RGD/galactose PET 
film for 1 week 
 
Since the pre-spheroid monolayer was only a transient stage between 1d and 3d 
during the self-assembly of hepatocyte 3D spheroids, we investigated the feasibility of 
stabilizing the pre-spheroid monolayer for longer-term application by co-conjugating of 
GRGDS peptide and galactose ligand onto the PET substratum. 
 
Hepatocyte attachment on bioactive substrata over time  
Cultured hepatocytes showed different attachment on various substrata during the 
7-day culture as shown by the total DNA content change (Fig. 16). Total DNA content 
was used as an estimate of viable cells attached to the substratum [3, 7]. The gradual 
decrease of the total DNA content was likely the result of the cell loss during the daily 
medium change. As the 3D spheroids began to detach from the substratum after day 3, a 
rapid drop in DNA content of hepatocytes cultured on PET-Gal was observed. On the 
other substrata, a slower decrease in DNA content was observed. The low total DNA 
content of hepatocytes cultured on PET-RGD was likely due to the lower cell number 
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initially seeded. Hepatocytes cultured on collagen substratum and PET-Hybrid showed 











Fig. 16 Hepatocyte attachment to bioactive substrata at various time points during 7-day 
culture as represented by the DNA content measurements. Data are means ± SD, n=10 
(*): P<0.05, (**): P<0.01, (N.S): not significant; 
 
Morphological changes of hepatocytes on bioactive substrata over time 
Significant influence of substratum characteristics and conjugated bioactive ligands 
on hepatocyte morphologies was observed. Fig. 17 presents confocal transmission images 
of the cultured hepatocytes on days 1, 3 and 6 after cell seeding. Within one day after 
seeding, hepatocytes formed small pre-spheroids on PET-Gal and non-spreading 
aggregates on PET-Hybrid (RGD: galactose = 1:1) while hepatocytes started to spread on 
PET-RGD and collagen substratum.  After 3 day culture, less compact 3D spheroids 
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Hybrid formed limited-spreading thick monolayer with distinct cell-cell boundary. On 
PET-RGD and collagen substratum, hepatocytes were fully-spread and flattened to form  
 
Fig. 17 Confocal transmission images of primary hepatocytes cultured on different 
substrata at various time points during 7-day culture (scale bar: 50 µm). 
 
 
2D monolayer. On day 6, mature spheroids were observed on PET-Gal and most of 
which detached from the substratum. Hepatocyte monolayer cultured on PET-Hybrid was 
stretched to ‘island-like’ thick monolayer which was distinct from the fully-spreading 2D 
monolayer of hepatocytes cultured on PET-RGD and collagen substratum. This thick 
hepatocyte monolayer on PET-Hybrid could be maintained for at least 1 week before 
detachment from the substratum. We named the thick monolayer of hepatocytes cultured 
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on PET-Hybrid as ‘3D monolayer’ which was distinct from the spreading ‘2D 
monolayer’ seen on PET-RGD and collagen substratum. We did not observe significant 
morphological differences in hepatocytes cultured on PET-Hybrid with different RGD: 
galactose ratios (1:5, 1:1, 5:1) (data not shown). This was consistent with the previous 
findings that RGD density as low as 0.1pmol/cm2 was sufficient to induce cell spreading 
[8]. Therefore, only the PET-Hybrid with 1: 1 ratio of RGD: galactose was used in 
subsequent experiments.  
 
F-actin, p-FAK and E-Cadherin distributions in hepatocytes cultured on bioactive 
substrata 
We hypothesize that the hepatocytes cultured as 3D monolayer on PET-Hybrid 
experience stronger cell-cell and weaker cell-substratum interactions than the 2D 
monolayer so as to maintain their 3D cell morphology. The 3D monolayer cultured on 
PET-Hybrid should also have a stronger cell-substratum interaction than the 3D 
spheroids on PET-Gal so as to adhere better to the culture substrata as observed above. 
Actin filament (F-actin) distribution has been used to characterize the relative strength of 
the cell-cell and cell-substratum interactions experienced by hepatocytes [9, 10]. The 2D 
monolayer of hepatocytes cultured on collagen substratum showed intense actin stress 
fibers throughout the cells indicating strong cell-substratum interaction (Fig. 18). 
Hepatocytes cultured as the 3D monolayer on PET-Hybrid had less actin stress fibers 
than the 2D monolayer on collagen substratum but more stress fibers than the 3D 
spheroids, indicating an intermediate strength of cell-substratum interaction. The 3D 
monolayer on PET-Hybrid exhibited cortical F-actin distribution similar to the 3D 
 - 95 -
spheroids cultured on PET-Gal indicating strong cell-cell interaction characteristic of 
hepatocytes in vivo [11].  
Focal adhesion kinase (FAK) is a key protein involved in modulating focal 
adhesion assembly in response to the cell-substratum interaction via integrin [12]. 
Integrin-mediated cell-substratum adhesion triggers autophosphorylation at the Tyr-397 
residue of FAK [13], so that the p-FAK distribution as intracellular clusters is a specific 
indicator of the cell-substratum interaction. The punctate p-FAK cluster signals were 
strong in the 2D and 3D monolayers and very weak in the 3D spheroids (Fig. 18) 
confirming that the 3D monolayer experienced stronger cell-substratum interaction and 
could adhere better to the substrata than the 3D spheroids.  
As a homophilic cell adhesion molecule to regulate recognition and interaction 
between cells, E-Cadherin has been shown to play an important role in the formation of 
3D hepatocyte spheroids [14]. We investigated the E-Cadherin expression as a specific 
indicator of cell-cell interaction. E-Cadherin was found to localize primarily at the cell-
cell boundary at relatively high level in 3D monolayer and spheroids but intracellularly 
and sparingly throughout the hepatocyte cytoplasm in the 2D monolayer. This confirms 
the stronger cell-cell interaction in the 3D monolayer and spheroids than the 2D 
monolayer.  
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Fig. 18 Confocal images of F-actin, p-FAK and E-Cadherin of hepatocytes after 3-day 
culture as the 3D spheroid, 3D monolayer and 2D monolayer contains 3D projection of 
the images (scale bar: 20 µm); E-Cadherin distribution (lower panel) also contains insets 
of single optical section to confirm whether E-Cadherin localizes at cell boundary. 
 
Hepatocyte functions in response to bioactive substrata 
Hepatocytes lost their differentiated functions when stretched as 2D monolayer but 
exhibited high levels of functions when cultured as 3D spheroids, in 3D microcapsules 
[15] or in 3D bioreactors [16]. Therefore, it is reasonable to hypothesize that the 
hepatocytes cultured as the 3D monolayer on PET-Hybrid should exhibit differentiated 
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functions more similar to the 3D spheroids than the 2D monolayer. Indeed, albumin 
secretion and urea synthesis by hepatocytes cultured on PET-Gal and PET-Hybrid were 
higher than those on collagen substratum over a 7-day culture with the most significant 
differences from days 3 to 7. The albumin secretion and urea synthesis by hepatocytes 
cultured on collagen substratum dropped mostly dramatically even though the functions 
of hepatocytes cultured on PET-Hybrid and PET-Gal also deteriorated slowly over time 
(Fig. 19A, 19B). Cytochrome P450 enzymes belong to a class of constitutive and 
inducible enzymes that metabolize many endogenous substrates, as well as numerous 
xenobiotics and therapeutic agents including APAP which was the model drug used for 
hepatotoxicity study [17]. CYP1A is the primary enzyme responsible for the metabolism 
of 7-ethoxyresorufin-O-deethylation (EROD) and the activity of the enzyme is known to 
be induced by 3-MC. Hepatocytes cultured on all substrata could maintain induced 
EROD activity over a 7-day culture (Fig. 19C). The induced EROD level was 
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Fig. 19 Liver-specific functions of hepatocytes on different substrata at various time 
points during 7-day culture: (A) Albumin secretion; (B) urea synthesis and (C) 3MC- 
induced EROD activity. The functional data were normalized against the DNA content 
per sample. Data are means ± SD, n=6. (*): p<0.05, (**): p<0.01, (N.S): not significant.  
(     : PET-Gal;       : PET-Hybrid;       : Collagen).     
 
4.3.2 GRGDS peptide as the adhesive cue to stabilize the hepatocyte pre-spheroid 3D 
monolayer 
 
Hepatocytes on the hybrid substratum (PET-Hybrid) could maintain 3D monolayer 
configuration without spheroid formation for up to 1 week with enhanced cell-cell 
interactions and better hepatocyte differentiated functions  than 2D hepatocyte monolayer 
on collagen substratum [18]. There is much similarity between the pre-spheroid 3D 
monolayer on PET-Gal discovered in Chapter 3 and the 3D monolayer stabilized on the 
PET-Hybrid here, in terms of the cell morphology, F-actin distribution. The role of the 
GRGDS peptide in the PET-Hybrid might be to 1) enhance the cell-substratum 
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prevent the pre-spheroid hepatocyte monolayer from forming 3D spheroids. We tested 
this hypothesis by first quantifying using ELISA the p-FAK expression of the 
hepatocytes cultured for a week on PET-Hybrid. p-FAK expression of the hepatocytes 
gradually increased during the first 3d culture on PET-Hybrid, and sustained over 6d (Fig. 
20). In contrast to the decrease of p-FAK expression as 3D spheroid formation on PET-
Gal at 3d (Fig. 11A), the sustained p-FAK expression of the hepatocytes on the PET-
Hybrid indicated the enhanced cell-substratum interactions upon the introduction of 
GRGDS peptide. We then tested whether GRGDS peptide is responsible for stabilizing 
the pre-spheroid monolayer via the prevention of the 3D spheroid formation. We added 
soluble GRGDS peptide to the culture media to potentially compete with the conjugated 
GRGDS peptide on the PET-Hybrid (Fig. 21). Indeed, soluble GRGDS peptide could 
destabilize the hepatocyte monolayer maintained on PET-Hybrid to form compact 3D 
spheroids presumably by counteracting with the conjugated GRGDS peptide. Soluble 
GRGDS peptide could also facilitate the detachment of 3D spheroids cultured on PET-
Gal from the substratum, as all the spheroids were observed in suspension after treatment, 
while some spheroids were still attached to the substratum in the control. Treatment of 
the soluble GRGDS for 24h caused slight toxicity to the hepatocytes as more single dead 
cells were observed in the treated samples than in the controls. The soluble galactose 
ligands did not induce any morphological changes of the 3D spheroids on the 
galactosylated substratum or the pre-spheroid monolayer on the hybrid substratum or the 





















Fig. 20 p-FAK expression of hepatocytes cultured on PET-Hybrid over 6 day culture 






Fig. 21   Stabilization of pre-spheroid 3D monolayer on a hybrid GRGDS/Galactose-PET 
substratum (PET-Hybrid), which could be destabilized by soluble GRGDS peptide.  
Phase-contrast images of hepatocytes at day 4 on PET-Gal, PET-Hybrid and collagen 
substratum in medium with soluble GRGDS peptide and normal medium as control. 
 
 






































 - 101 -
4.3.3 Example of applying the stabilized hepatocyte pre-spheroid 3D monolayer for 
model drug hepatotoxicity study 
 
Response to acetaminophen-induced hepatotoxicity in hepatocytes cultured on bioactive 
substrata  
Acetaminophen (APAP), a commonly used analgesic, is known to cause 
hepatotoxicity when ingested in large quantities in both animals and man, especially 
when co-administered after chronic ethanol consumption [19]. Hepatotoxicity stems from 
APAP biotransformation by cytochrome P450 (P450) enzymes to a toxic intermediate 
which can bind to tissue macromolecules, thereby initiating cellular necrosis [19]. 
CYP1A, CYP2E and CYP3A are the most active isoforms that can metabolize APAP [20, 
21]. Induction of CYP activities results in increased APAP toxicity [22]. We investigated 
the responses to hepatotoxicity caused by APAP itself and co-administration with 3-MC 
to hepatocytes cultured on PET-Gal, PET-Hybrid and collagen substratum. The co-
administration of 3-MC, an inducer of CYP 1A was conducted as the evaluation of drug-
drug interaction which would lead to higher toxicity.  
The survival ratio of hepatocytes cultured on different substrata after exposure to 
APAP or APAP co-administered with 3MC for 24h (Fig. 22A) or 48h (Fig. 22B) were 
measured using a MTS viability assay. In drug-free condition, hepatocytes cultured on all 
substrata showed similar basal level of viability (data not shown). In the presence of 
drugs, the 3D monolayer cultured on PET-Hybrid showed similar level of viability as the 
3D spheroids cultured on PET-Gal which was more sensitive to hepatotoxicity than the 
2D monolayer cultured on collagen substratum. Exposure to low concentration of APAP 
(2mM) for 24h was almost non-toxic to the 2D monolayer (survival ratio of 98%) but  
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slightly toxic to the 3D spheroids (survival ratio of 84%) and the 3D monolayer (survival 
ratio of 89%); 48h exposure to 2mM APAP caused considerable hepatotoxicity to the 2D 
monolayer (survival ratio of 64%) and more severe toxicity to the 3D spheroids (survival 
ratio of 57%) and  the 3D monolayer (survival ratio of 59%). When exposed to high 
concentration of APAP (10mM) for 24h, the 3D spheroids (survival ratio of 44%) and the 
3D monolayer (survival ratio of 38%) showed approximately twice more sensitive to 
APAP-induced hepatotoxicity than the 2D monolayer  (survival ratio of 80%); 48h 
exposure to 10mM APAP killed most of the cells on different substrata. The ‘amplified 
effect of hepatotoxicity’ of 3MC when co-administered with APAP became significant 
only after 48h exposure. Almost all cells were dead when exposed to 10mM APAP and 
3MC on different substrata. When exposed to 2mM APAP and 3MC for 48h, the 3D 
spheroids (survival ratio of 19%) and the 3D monolayer (survival ratio of 28%) showed 
approximately 3 times and twice more sensitivity to hepatotoxicity than the 2D 
































Fig. 22 Response of hepatocytes cultured on different substrata to APAP-induced 
hepatotoxicity. Survival ratios of hepatocytes exposed to different concentrations of 
APAP or APAP co-administered with 3MC for 24 hours (A) and 48 hours (B). Data are 
means ± SD, n=10 (*):  P<0.05, (**): P<0.01, (N.S): not significant. (    : PET-Gal;     : 
PET-Hybrid;       : Collagen). 
 
 
4.4    Conclusions and discussions 
 
In this chapter, stabilization of the 3D hepatocyte monolayer was achieved on a 
GRGDS/Galactose Hybrid PET film for one week. The role of the co-conjugated 
GRGDS peptide on the PET-Hybrid was investigated as to enhance the cell-substratum 
interaction, which contributes to the stabilization of the 3D hepatocyte monolayer from 
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attachment of the hepatocyte 3D monolayer cultured on hybrid substratum make the 
hybrid substratum a promising alternative for conventional collagen-coated 2D 
substratum for hepatocyte-based applications like microplate-based metabolism and 
hepatotoxicity testing. As shown by the exemplary hepatotoxicity study of APAP, 
hepatocyte cultured on the hybrid substratum showed more sensitivity towards APAP 
than hepatocytes cultured on collagen. The 3D hepatocyte monolayer configuration is 
expected to provide improved in vitro prediction of the xenobiotics pharmaco-
kinetics/dynamics data that better recapitulate the in vivo biological responses.  
The higher sensitivity of hepatocytes cultured on PET-hybrid and on PET-Gal to 
APAP-induced hepatotoxicity might be caused by the higher CYP45O enzymatic 
activities. The ‘amplified effect of hepatotoxicity” of the co-administered inducer (3MC) 
might be due to the higher inducibility of CYP 450 enzymes of hepatocytes cultured on 
PET-hybrid and PET-Gal. The influence of substratum on hepatocyte drug response may 
also be an important issue for future study in order to develop a reliable in vitro culture 
model for toxicity assessment which allow good predictions and correct decisions for 
drug development. 
In summary, identification of a pre-spheroid 3D hepatoeyte monolayer and 
stabilization of this hepatocyte culture model by using the GRGDS/galactose hybrid 
substratum offer many advantages over the current 2D and 3D hepatocyte in vitro culture 
models as listed below:  
• Compared with conventional 2D hepatocyte monolayer cultured on collagen- 
coated substratum, 3D hepatocyte monolayer cultured on GRGDS/galactose 
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hybrid substratum exhibited improved cellular structure and polarity, enhanced 
cell-cell interaction and better differentiated functions  
• 3D hepatocyte monolayer exhibited better attachment and presumably mass 
transfer than 3D spheroids 
• Uniform monolayer morphology compared with the mixture of hepatocyte 
spheroids and monolayer on Primara dish [23] 
• More effective mass transfer achieved in the ‘collagen-free’ bioactive sandwich 
culture configuration  
• Simple and quantitative controllable bioactive cues in the synthetic polymeric 
biomaterials compared to natural extracellular matrix with unidentified 
component and batch-to-batch variation 
• Chemically and mechanically stable for long-term storage and cryopreservation  
• Hepatocytes cultured in normal culture medium without exposure to high-level of 
hormone compared to the highly functional monolayer cultured on Primara dish 
maintained by high concentration of DEX  
• Biocompatible and optically clear, which is ready to be adapted to the micro- 
plate-based ADME/TOX screening platform or membrane-based bioreactor  
 
Due to the uniformity of the 3D hepatocyte monolayer maintained on the optically 
clear hybrid bioactive GRGDS/galactose substratum, the system can also be potentially 
used as an alternative for collagen-coated substratum in the hepatocyte-based high 
content screening. This enables monitoring of multiple assay parameters (such as 
mitochondrial trans-membrane potential, intracellular free calcium, plasma membrane 
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integrity) in one step and elucidating cellular events and response more mimic to 
hepatocytes in the liver. 
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Longer-term stabilization of the 3D hepatocyte 
monolayer using a novel synthetic sandwich 
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5.1 Introduction   
 
We have identified an unstable 3D hepatocyte monolayer stage before spheroid 
formation after 1 day of culture on galactosylated PET film in Chapter 3, and achieved 
the short-term stabilization of the 3D hepatocyte monolayer on the GRGDS/Galactose 
Hybrid PET film for one week in Chapter 4, which can be readily used for hepatocyte-
based drug metabolism/ hepatotoxicity testing. In this chapter, we have established an 
ECM-free synthetic sandwich culture by overlaying another functional support at the top 
of 3D monolayer in order to 1): stabilize the hepatocyte 3D monolayer for longer-term 
culture 2): further induce the adoption of in vivo liver structures such as polarity with 
higher liver function, 3) constitute a novel synthetic sandwich culture model with 
improved performances compared with the conventional ECM-based sandwich culture. 
The 3D hepatocyte monolayer maintained in the synthetic sandwich culture aimed to 
replace the conventional ECM-based sandwich culture, which can be useful in 
hepatocyte-based applications with longer term culture, such as in the chronic drug 
metabolism/ hepatotoxicity testing, bioreactor and BLAD.       
Primary hepatocytes are anchorage-dependent cells performing major differentiated 
functions of the liver. In vivo, hepatocytes are organized into a polarized epithelium with 
distinct apical (bile canalicular) and basal (sinusoidal) domains [1]. The basal domain of 
the hepatocytes is in contact with a complex extracellular matrix (ECM) containing 
fibronectin, laminin, collagen I-V, and proteoglycans in the space of Disse [2]. The 
interactions of hepatocytes with the ECM environment are important for hepatic polarity 
and differentiated function maintenance [3]. In standard in vitro culture, primary 
hepatocytes cultured on substrates coated with ECM protein, such as collagen or 
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fibronectin, typically exhibit spreading morphology with deteriorating differentiated 
functions and nearly no polarized structure [4]. This deteriorating process could be 
rescued by overlaying another ECM layer, such as collagen or basement membrane 
(MatrigelTM), which mimics the ECM distribution in the space of Disse. Hepatocyte 
sandwich culture between double layers of ECM is an in vitro model with re-established 
hepatic polarity and stable differentiated functions [3, 5, 6]. The hepatocyte sandwich 
culture has been adopted in liver physiology studies [7, 8], drug metabolism/toxicity 
testing [9] and hepatocyte-based bioreactors [10, 11]. Here we adopt the sandwich 
configuration to stabilize the transient 3D hepatocyte monolayer cultured on 
galactosylated PET film by overlaying a bioactive top-support to replace the functions of 
natural ECM. This ‘ECM-free’ synthetic sandwich culture developed here, addressed the 
limitations of the conventional ECM-based sandwich culture, such as complex molecular 
compositions of the ECM with batch to batch variation [12], uncontrollable ECM coating, 
mass transfer barriers induced by the gelled ECM-coated top support (hindering the 
exchange of nutrients, xenobiotics or biochemical signals with the bulk culture medium), 
and shedding of the ECM coating from the top support during culture.   
A variety of synthetic substrata with bioactive components, such as cell adhesion 
peptides: Arg-Gly-Asp (RGD) [13], Tyr-Ile-Gly-Ser-Arg (YIGSR) [14], Gly-Phe-Hyp-
Gly-Glu-Arg (GFOGER) [15] or sugar ligands: galactose [16], glucose [17], lactose [18], 
have been used for cell culture to replace natural ECM with well-controlled material 
properties and cellular responses.. Here, we established a synthetic sandwich culture by 
overlaying the 3D hepatocyte monolayer on the galactosylated PET film (bottom 
substratum) with a porous PET Track-etched [19] membrane (top support). Since the 
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biochemical compositions of ECM play essential roles in regulating hepatocyte 
morphology, polarity and differentiated functions in ECM-based sandwich culture [20-
22], we investigated the influence of three different top support (galactosylated, GRGDS-
modified or non-modified PET TE membrane) on the stabilization of hepatocyte 
morphology, polarity and differentiated functions in the 3D hepatocyte monolayer of the 
synthetic sandwich culture. The synthetic sandwich culture with GRGDS-modified PET 
TE membrane (top support)/galactosylated PET film (bottom substratum) exhibited the 
optimal performances, in terms of stabilizing the 3D monolayer morphology, re-
establishing hepatocyte polarity and maintaining other differentiated functions. 
We compared this GRGDS-modified PET TE membrane/galactosylated PET film 
synthetic sandwich culture of 3D hepatocyte monolayer with the ‘gold standard’ collagen 
sandwich hepatocyte culture. 3D hepatocyte monolayer in the synthetic sandwich culture 
exhibited similar dynamic process of polarity formation and biliary excretion, improved 
mass transfer, enhanced cell-cell interaction, albumin/urea synthesis and detoxification 
functions compared with the hepatocytes in the collagen sandwich culture. 3D hepatocyte 
monolayer maintained in this novel synthetic sandwich culture can replace the 
conventional ECM-based sandwich culture for relevant hepatocyte-based applications 
such as drug metabolism/toxicity testing and hepatocyte-based bioreactors [7, 8].  
 
5.2   Materials and methods 
 
Materials 
Biaxially oriented polyethylene terephthalate (PET) film of ~100µm in thickness 
was purchased from Goodfellow Inc. (Cambridge, U.K). Polyester membrane filters 
(PET track-etched membranes) were purchased from Sterlitech Corporation (WA, USA). 
 - 112 -
This membrane was characterized by a thickness of 9µm, a pore density of 
3×107pores/cm2, and a mean pore diameter of 0.8µm. The galactose ligand, 1-O-(6’-
aminohexyl)-D-galactopyranoside (AHG, M.W. 279) was synthesized according to the 
method developed previously [23-25] and verified by NMR spectroscopy. GRGDS 
peptide was bought from Peptides International (Kentucky, USA).  Minusheet carriers 
were purchased from Minucells and Minutissue Vertriebs GmbH (Bad Abbach, 
Germany). Primary rabbit anti-E-Cadherin and anti-GAPDH antibody were purchased 
from Santa Cruz (CA, USA); Primary anti-CD147 monoclonal antibody was purchased 
from Serotec (Raleigh, USA); Primary rabbit anti-MRP2 antibody was purchased from 
Zymed laboratories (San Francisco, USA); Secondary TRITC-conjugated goat anti–
rabbit IgG and FITCconjugated goat anti–mouse IgG were purchased from Molecular 
Probes (Invitrogen, Singapore). All other chemicals were purchased from Sigma-Aldrich 
Singapore unless otherwise stated.  
 
 Fabricating bioactive PET film conjugated with galactose as the bottom substratum  
Argon plasma activated PET film was firstly functionalized by grafting with acrylic 
acid (AAc) under UV irradiation and then cut into circular disks with diameter of 12mm 
in order to fit into minusheet carriers, followed by conjugation with galactose ligand 
(AHG) using EDC-NHS chemistry, as reported previously [26, 27].  
 
Fabricating bioactive PET track-etched membrane conjugated with Galactose or 
GRGDS as the top support  
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The PET TE membrane was cut into circular disks with diameter of 12mm in order 
to fit into minusheet carriers. The non-modified PET TE membrane was functionalized 
by generating carboxylic groups directly from the track-etched polyester bulk material 
using a revised protocol [28]. Briefly, the non-modified PET TE membrane was first 
oxidized with KMnO4 in 1.2N H2SO4 (50g/L) at 60oC for 1h followed by rinsing 
successively with 6N HCl (2×30min) and DI water (3×10min). For GRGDS peptide or 
galactose ligand (AHG) conjugation, 300µl of MES buffer (50mM, pH of 5.5) containing 
10mg EDC and 2mg sulfo-NHS were added to each well of the 24-well plate containing 
the PET TE membrane to activate the carboxylic groups by forming NHS esters. After 2h 
activation at room temperature, the MES solution was completely removed and 
replenished with 300µl phosphate buffer (0.1M, pH of 7.4) containing ligands and 
allowed to react for 48h at 4oC under shaking (300rpm in a Eppendorf thermomixer). 
GRGDS-modified or galactosylated PET TE membrane was fabricated by reaction with 
0.2mg GRGDS peptide or 1mg AHG respectively. After ligand conjugation, each 
membrane was blocked with 0.5% ethanolamine solution for 15min to quench non-
specific interactions due to the un-reacted carboxylic groups. The microplates containing 
different substrata were sterilized by soaking with 70% ethanol for 3h and then rinsed 3× 
with PBS before cell culture. 
 
Characterization of the bioactive PET film and PET TE membranes 
The density of carboxylic groups on the PET film or PET TE membrane was 
determined by a colorimetric method using Toluidine Blue O staining [25, 29]; X-ray 
photoelectron spectrometry (XPS) was used to qualitatively determine the surface 
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chemical composition. XPS measurements were made on Quantera Scanning XPS 
Microprobe (ULVAC-PHI) with a Al Kα X-ray source (1486.7eV photons). Pass energy 
were 224eV (survey scan) and 55eV (narrow scan).  X-ray source works at 40W, 15kV 
beam size at 200um.  The pressure in the analysis chamber was ~2x108 Torr. The angle 
of analyzer was directed at 45° to the sample's surface. The density of the GRGDS or 
galactose ligands on PET track-etched membrane was quantified by Reverse-phase 
HPLC method as developed previously [26].  Briefly, the conjugated ligands were 
hydrolyzed off the membrane using an Acid Hydrolysis Station (C.A.T. GmbH & Co.) in 
6N HCl at 110oC for 24h under vacuum. The cooled hydrolyzed solution was filtered into 
a new vial and evaporated under nitrogen. The hydrolyzed ligands from the membrane 
were re-suspended in 50µl DI-water and derivatized using ATTO-TAG™ CBQCA 
Amine-Derivatization Kit (Molecular Probes) for fluorescence detection after separation 
on a reverse phase C-18 column in HPLC (Agilent Technology). 
 
Hepatocyte isolation and culture in synthetic and collagen sandwich culture 
Hepatocytes were harvested from male Wistar rats by a two-step in situ collagenase 
perfusion method [30]. Viability of the hepatocytes was determined to be >90% by 
Trypan Blue exclusion assay with a yield of >108 cells/rat.  
Freshly isolated rat hepatocytes were seeded onto different substrata contained in 
24-well plate (NUNC) at the density of 105cells/cm2 and cultured in William’s E culture 
medium supplemented with 1mg/ml BSA, 10ng/ml of EGF, 0.5µg/ml of insulin, 5nM 
dexamethasone, 50ng/ml linoleic acid, 100units/ml penicillin, and 100µg/ml 
streptomycin.  
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In the synthetic sandwich culture, hepatocytes were first seeded on the 
galactosylated PET film for 3h to achieve full attachment. Culture medium containing the 
unattached cells was removed; and the attached hepatocytes were cultured in fresh 
medium for one day until the PET TE membrane top support (galactosylated; GRGDS-
modified or unmodified) was overlaid. The sandwich construct (bottom galactosylated 
PET film/ sandwiched hepatocytes/top PET TE membrane) was secured using the O-
rings on the minusheet carriers. In the conventional collagen sandwich culture, the 
bottom collagen-coating substratum was prepared by spotting 40µl neutralized Type I 
collagen solution (8ml collagen, 1ml 0.1M NaOH, 1ml 10×PBS,  6ml 1×PBS; Vitrogen, 
Palo Alto, CA) onto the 12mm glass coverslip before incubation at 37oC overnight for 
gelation. Hepatocytes seeded on the collagen-coated coverslip were incubated for 1h for 
full attachment before media replenishment and then cultured for 24h. The culture 
medium was removed and a layer of un-gelled collagen was overlaid on top of the cells. 
Gelation of the collagen overlay was allowed to occur at 37oC for 3h before fresh 
medium was replenished.  
 
FITC-dextran diffusivity measurements 
Measurement of the diffusivity of Fluorescein Isothiocyanate-conjugated dextrans 
(FITC-dextrans, with molecular weight: 9.5 kDa, 70 kDa and 150 kDa) through the 
various PET TE membrane top support and collagen top support were based on a donor-
receptor compartment model reported previously [31]. For the measurement of diffusivity 
of FITC-dextrans through the PET TE membrane top supports, the membrane was 
clamped between the receptor and donor compartments using minusheet carriers. Donor 
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compartments were filled with 20µl of 0.2 wt % FITC-dextran in PBS, while receptor 
compartments were filled with 200µl of PBS. Samples were taken from the receptor 
compartment every hour and replaced with fresh PBS. For the measurement of diffusivity 
of FITC-dextrans through the collagen layer, 20µl of 0.2 wt % FITC-dextran in PBS was 
maintained in the glass coverslip and 40µl of collagen was added at the top. The whole 
construct was maintained in minucell carriers and incubated for 3h in 37oC to facilitate 
the gelation of collagen. 200µl PBS was added on the receptor compartment; and samples 
were taken from the receptor compartment every hour and replaced with fresh PBS. The 
concentrations of FITC-dextran were measured at 490nm excitation/525nm emission 
against FITC-dextran standards using the microplate reader (Tecan Safire2, Switzerland). 
 
Scanning electron microscopy 
3.7% paraformaldehyde-fixed samples were rinsed in PBS and then post-fixed with 
osmium tetraoxide for 1h. Dehydration was accomplished using a graded series of 
ethanol (25%, 50%, 75%, 95%, and 100%). The samples were then critical point dried for 
2h in absolute alcohol; mounted onto a brass stub and sputter-coated with platinum (JFC-
1600, JEOL), before being viewed under a field emission scanning electron microscope 
(JSM-7400F, JEOL). 
 
Western blot  
Hepatocytes (total cell number >2millon) in different culture models were lysed 
with RIPA buffer (50mm Tris-HCL, 150mM NaCl, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS) supplemented with protease inhibitor cocktail (Roche, 
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Singapore) for 30min at 4oC. Lysates then were clarified by centrifugation at 10,000g for 
20 min at 4oC. The protein concentration per sample was quantified by Dc protein 
Reagent assay (Bio-rad, U.S) which was diluted in sample loading buffer (2% SDS, 
80mM Tris-HCl, 10% glycerol, 0.1% Bromophenol blue, 5% 2-mercaptoethanol) and 
heated for 5 min at 95oC. 15µg protein sample per lane was loaded and fractionated by 
7.5% SDS-PAGE gel and transferred to a PVDF membrane (Millipore, U.S) by semi-dry 
electro-blotting. The membranes were blocked with 3% non-fat milk in TBS-T for 1h at 
room temperature and incubated with primary rabbit anti-E-Cadherin (1:500 diluted in 
TBS-T buffer) or rabbit anti-GAPDH (1:1000) overnight at 4oC. After 5× washing with 
TBS-T buffer, the membrane was incubated with secondary goat peroxidase-conjugated 
anti-rabbit or anti-mouse IgG 1:10,000 diluted in 0.5% non-fat milk for 1h at room 
temperature. After 5× washing with TBS-T buffer, the membrane was treated with 
Amersham ELC plus reagent (GE Healthcare, UK) ; and light emission was detected by 
exposing the membrane to a Hyperfilm (GE Healthcare, UK). Films were developed in a 
KODAK Medical X-ray Processor (KODAK, USA) and imaged by a KODAK IMAGE 
Station 2000MM (KODAK, USA). Relative quantification of western blot was performed 
by measuring the mean pixel intensity associated with individual bands with PhotoShop 
7.0 software. A background noise value was subtracted from each protein band to obtain 
a corrected mean pixel intensity value,.  
 
Biliary excretion of fluorescein  
3µg/ml of fluorescein diacetate (Molecular Probes, Eugene, Oregon) was incubated 
with the hepatocytes at 37oC for 45min in culture medium [7] to visualize the biliary 
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excretion of fluorescein. The cells were rinsed and fixed before being imaged under a 
confocal microscope (Fluoview 300, Olympus) using a 40× water lens. Image-pro Plus 
software (MediaCybernetics, USA) was used to process the images and quantify the 
fluorescein localization in the inter-cellular sacs between hepatocytes. 
 
Method of quantifying the biliary excretion of FDA with Image-pro Plus (IPP) 
 
A confocal image of FDA staining (Fig. 30A) was first imported into IPP and then 
segmented by using the ‘Segmentation’ tool (Fig. 30B). A certain threshold value of pixel 
(from 0 to 255) was set, based on observation, to eliminate the background noises and 
extract the fluorescent signals in the image (Fig. 30C). The total area occupied by all 
extracted signals, which represents the total areas covered by FDA-containing cells, was 
quantified by using the ‘Count/Size’ tool (IPP would count the areas of all the objects 
within an image; the total area is the sum of the areas of all the objects). 
To extract the fluorescent signals representing the FDA excreted into the inter-
cellular sacs, the threshold value of pixel in the segmented image was further increased 
until all the fluorescence signals from inside the cells (normally much weaker than the 
fluorescent signals of the excreted FDA) were eliminated (Fig. 30(D1-D3)). Since the 
option of threshold is only based on observation and final calculation of the excreted 
FDA is very much subjective to a chosen threshold value, we set three different 
thresholds from relatively low (Fig. 30 (D1)), medium (Fig. 30 (D2)) to relatively high 
(Fig. 30 (D3)) for each image to compromise the arbitrary choice of threshold (We don’t 
do this for total cell area quantification, since the calculation is not very sensitive to a 
chosen threshold value within a certain range). The area occupied by all extracted signals, 
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which represent the total areas covered by the biliary excreted FDA, was quantified by 
using the ‘Count/Size’ tool. One issue for FDA staining quantification is that there are 
some highly fluorescent signals from the cytoplasm (as indicated by the arrows in the Fig. 
30 (D1-D3)) which cannot be eliminated by increasing the threshold. Compared with the 
excreted FDA signal in the cell-cell boundary, these kinds of highly fluorescent signals 
from the cytoplasm normally occupy larger area. Therefore we get rid of these artifacts 
from these highly fluorescent cytoplasm signals by setting the upper limit of object area 
as 500, which is roughly the area of a cell. In this way, only the highly fluorescent signal 
occupying areas less than 500, which normally represent the extracted FDA signal, will 
be counted.  
The biliary excretion of a FDA-staining image (BE) was indicated by the ratio of 
the area of excreted fluorescein in intra-cellular sacs (AEF) to the total area covered by 
FDA-containing cells (TAC). BEF= %
TAC
AEF . For each condition, more than five original 
images have been randomly chosen to get statistically meaningful results.  
 
Immunofluorescence microscopy 
For F-actin staining, the cells were fixed using 3.7% paraformaldehyde (PFA), 
blocked in 10% fetal calf serum (FCS) at room temperature for 1h, permeabilized for 
5min in 0.1% Trion X-100 in 1% bovine serum albumin solution (BSA), incubated with 
TRITC-phalloidin (1µg/ml) for 20min and then wash 3× with PBS before imaging. For 
double-staining of MRP2/CD147, cells fixed with PFA were blocked in 10% FCS at 
room temperature for 1h. Samples were incubated with the primary anti-CD147 
monoclonal antibody and primary anti-MRP2 rabbit polyclonal antibody (1:10 dilution) 
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overnight at 4oC. After rinsed 3× with PBS, the samples were incubated with the 
corresponding secondary antibodies (TRITC-conjugated goat anti–rabbit IgG; FITC-
conjugated goat anti–mouse IgG) at room temperature for 1h and rinsed 3× with PBS 
before being mounted in FluorSaveTM (Calbiochem, CA). The samples were imaged 
with a Fluoview-300 confocal microscope 15 (Olympus, Japan) using a 63× water-
immersion objective (NA1.2). 
 
Measurement of hepatocyte differentiated functions [32] 
All functional data were normalized to 106 cells. A Rat Albumin ELISA 
Quantitation Kit (Bethyl, Texas) was used for the measurement of daily albumin 
production; Urea synthesis of the hepatocyte culture incubated in culture medium with 
2mM NH4Cl for 90min was measured with Urea Nitrogen Kit (Stanbio, Texas); The 7-
ethoxyresorufin-O-deethylation (EROD) assay was used to measure the de-ethylation 
activity of cytochrome P450 (CYP) 1A-associated mono-oxygenase enzymes, which was 
initiated by incubating the hepatocytes with 8µM 7-ethoxyresorufin in culture medium at 
37oC for 4h. The amount of resorufin converted by the enzymes was calculated by 
measuring the resorufin fluorescence in the incubation medium at 543nm 
excitation/570nm emission against resorufin standards using the microplate reader (Tecan 
Safire2, Switzerland). All the EROD cytochrome P450 1A detoxification activities were 
normalized relative to freshly isolated hepatocytes. 
 
Statistical Analysis 
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Results were presented by mean ±standard deviation (M ±S.D.). Each result was 




5.3   Results 
   
Fabrication and characterization of bioactive PET track-etched (TE) membranes to 
construct the synthetic sandwich culture 
The synthetic sandwich culture was constructed by a galactosylated PET film as the 
bottom substratum and a PET TE membrane (GRGDS-modified or galactosylated or non-
modified) as the top support. The entire sandwich construct was secured in the Minusheet 
Carriers (Minucells and Minutissue Vertriebs GmbH) (Fig. 23A). 
The fabrication and characterization of the galactosylated PET film (bottom 
substratum) were described previously [26]. We fabricated here GRGDS-modified or 
galactosylated PET TE membranes (top support, Fig. 23B) based on the commercially-
available PET TE membrane which is naturally hydrophilic with carboxylic and hydroxyl 
groups presented on the bulk material after the ‘track-etching’ treatment. The density of 
the carboxylic groups presented in the non-modified PET TE membrane manufactured by 
Sterlitech is 5.8±0.13nmol/cm2 as quantified by TBO assay. We further increased the 
functional carboxylic group density to 19.9±2.5nmol/cm2 by oxidizing the membrane 
using KMnO4 in H2SO4 solution. XPS C 1s core-level peak components of the non-
modified PET TE membrane (Fig. 24A) consist of the aromatic carbon at the binding 
energy (BE) of 284.6 eV, carbon singly bonded to oxygen at the BE of 286.2 eV, and 
carboxyl carbon at the BE of 288.6 eV in an approximate area ratio of 3.5:1:0.6. The area 
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ratio is slightly different from the chemical structure of PET (with the ratio of 3:1:1) 
probably due to the particle bombardment and alkaline hydrolysis of the polyester bulk 
material during the ‘track etching’ treatment. The C 1s core-level peak component area 
associated with the O-C=O species increases in the oxidized PET TE membrane 
compared with the non-modified PET TE membrane indicating the oxidation of the 
hydroxyl groups into carboxylic groups, while the area associated with the C-O species 
decreases accordingly (Fig. 24B).  
GRGDS peptide or Gal ligand (AHG) was covalently conjugated onto the oxidized 
PET TE membrane activated by EDC and sulfo-NHS. C 1s core-level spectra of both the 
GRGDS-modified and galactosylated PET TE membranes reveal changes in the surface 
chemical composition after surface modification (Fig. 24C, 24D). Successful conjugation 
of GRGDS peptide or Gal ligand onto the oxidized PET TE membrane was confirmed by 
the appearance of two new peak components at the BEs of 287.6 and 285.7 eV, 
attributable to the CONH and the CN functional groups, respectively, and the substantial 
decrease in the O-C=O peak component intensity. The conjugated GRGDS peptide or 
Gal ligand was hydrolyzed off the PET TE membrane, derivatized into fluorescence 
substances, and quantified by RP-HPLC. The final density of the conjugated GRGDS 
peptide or Gal ligand on the PET TE membrane was 0.62±0.23nmol/cm2 or 
1.18±0.34nmol/cm2, which showed ~3% or ~6% surface functionality respectively.  
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PET TE membrane as top-support
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Fig. 23 Schematic diagrams of the synthetic sandwich construct for hepatocyte 
culture (A) and surface modification method to conjugate GRGDS or galactose ligand 
onto the PET TE membrane (B).
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Fig. 24 XPS C 1s core-level spectra of (A) the non-modified PET TE membrane; (B) the 
oxidized PET TE membrane; (C) GRGDS-modified PET TE membrane and (D) 
galactosylated PET TE membrane. 
 
 
Stabilization of the hepatocyte pre-spheroid 3D monolayer using the synthetic sandwich 
configuration for 2 weeks 
 
The synthetic sandwich culture was constructed by overlaying the hepatocytes 
cultured on the galactosylated PET film (bottom substratum) with three top supports 
(galactosylated, GRGDS-modified or non-modified PET TE membrane). As reported 
previously [33], hepatocytes cultured on the galactosylated PET film formed  a 3D 
hepatocyte monolayer between day 1 and day 3 after cell seeding (prior to hepatocyte 
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spheroid formation), which exhibited improved cell polarity, cell-cell interactions, and 
enhanced differentiated functions compared to conventional 2D hepatocyte monolayer on 
collagen substratum. We investigated here the effects of the 3 top supports on the 
morphology, cytoskeleton distribution, urea secretion and detoxification functions of the 
sandwiched 3D hepatocyte monolayer. Top support was overlaid 24h after seeding 
hepatocytes onto the galactosylated PET film when the hepatocytes aggregated into 
island-like clusters [33]. The sandwiched hepatocytes continuously migrated horizontally; 
and the island-like clusters merged into a monolayer in the synthetic sandwich culture 
with all the 3 top supports. Overlaying hepatocytes with galactosylated or GRGDS-
modified PET TE membrane induced within 12h dramatic re-organization of the F-actin 
from cytosolic distribution into a cortical distribution especially near the cell-cell contact 
(reminiscent of 3D cell characteristic, [34]); while overlaying with non-modified PET TE 
membrane did not effectively induce the similar F-actin re-organization (Fig. 25).  After 
one-week culture, hepatocyte multi-layers were formed in the synthetic sandwich culture 
with the galatosylated and non-modified PET TE membrane top supports; while the 
synthetic sandwich culture with the GRGDS-modified PET TE membrane top support 
could stabilize the hepatocyte monolayer morphology (Fig. 25). Hepatocytes in the 
synthetic sandwich culture with the GRGDS-modified PET TE membrane top support 
exhibited higher urea production and EROD cytochrome P450 1A activity than the 
synthetic sandwich culture with the galactosylated or non-modified PET TE membrane 
top supports (Fig. 26). The GRGDS-modified PET TE membrane (top 
support)/galactosylated PET film (bottom substratum) synthetic sandwich culture is 
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therefore further characterized for culturing hepatocytes over a period of two weeks in 
comparison with the gold standard collagen sandwich [7, 35].  
 
Fig. 25 Effects of the synthetic sandwich culture with three different top supports 
(galactosylated, GRGDS-modified or non-modified PET TE membrane) on the 
sandwiched hepatocytes: stabilization of the monolayer morphology (first panel) and F-
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Fig. 26 Hepatocyte differentiated functions in synthetic sandwich culture with ●: non-
modified ▲: GRGDS-modified ▼: galactosylated PET TE membrane.   
 
Mass transfer in synthetic vs. collagen sandwich culture 
FITC-dextrans with molecular weights of 9.5, 70, and 150kDa (representing a range 
of molecules in the culture medium) were used to measure the mass transfer across the 
GRGDS-modified PET TE membrane top support in the synthetic sandwich culture and 
the gelled-collagen top layer in the collagen sandwich culture. For FITC-dextrans with all 
the selected sizes, an approximately two fold increase in mass transfer was observed 
across the GRGDS-modified PET TE membrane over the gelled-collagen layer (Table. 4). 
The results indicate that the synthetic sandwich culture can achieve better mass transfer 
between hepatocytes and the culture medium than the collagen sandwich culture.  
 
Table. 4 Diffusivity of FITC-dextran of various molecular weights across the GRGDS-
modified PET TE membrane [PET] and gelled collagen layer [Collagen].  
      Molecular Weights (kDa)          Diffusivity × 108 (cm2/s) [PET]       Diffusivity × 108 (cm2/s) [Collagen]                
                     9.5                                    4.58±0.44                                 2.26±0.56                         
                     70                                     4.38±0.56                                 2.04±0.69                         
                     150                                   3.53±0.49                                1.70±0.53                                               
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Cell morphology and cell-cell interactions in synthetic vs. collagen sandwich culture  
SEM images of hepatocytes maintained in both the synthetic and collagen sandwich 
cultures 48h after sandwich assembly were analyzed for cell morphology and cell-cell 
interactions. 3D hepatocyte monolayer in the synthetic sandwich culture form tightly-
organized cell-cell contacts with smooth surface, which mimic the cell-cell interaction 
pattern in 3D hepatocyte spheroids formed on galactosylated PET film (PET-Gal) (Fig. 
27A). In contrast, hepatocytes in the collagen sandwich culture are generally more 
loosely interacting with each other; and 2D hepatocyte monolayer on the collagen 
substratum exhibits spreading morphology with clearly demarcated cell-cell boundaries. 
We further investigated the cell-cell interactions in these four culture conditions by 
examining the expressions of a cell-cell adhesion protein E-Cadherin (Fig. 27B). The E-
Cadherin protein expression level is the highest in the ‘gold-standard’ 3D hepatocyte 
spheroids on PET-Gal; followed by the 3D hepatocyte monolayer in the synthetic 
sandwich culture, which is significantly higher than the E-Cadherin expression level of 
the hepatocytes in collagen sandwich culture and  the 2D hepatocyte monolayer on 
collagen substratum. 3D hepatocyte monolayer in synthetic sandwich culture therefore 
enables better cell-cell interactions than the collagen sandwich culture.  





Fig. 27 Cell morphology and cell-cell interaction in synthetic vs. collagen sandwich 
cultures: (A) SEM images of hepatocytes maintained in synthetic and collagen sandwich 
culture 48h after top support overlaying as well as the 3D hepatocyte spheroids on PET-
Gal and 2D hepatocyte monolayer on collagen substratum at the same time point. (low 
magnification at upper panel and high magnification at lower panel) (B) Western blot and 
relative quantification of E-Cadherin and GAPDH expression of the hepatocytes cultured 
in the synthetic sandwich culture, collagen sandwich culture, as 3D spheroids on PET-
Gal and as 2D monolayer on collagen; GAPDH expression was used as loading control. 
 Polarity formation and biliary excretion in synthetic vs. collagen sandwich culture 
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A key feature of the sandwich culture is its ability to re-establish in vivo-like 
hepatocyte polarity. In the earlier stage of polarity formation, bile canaliculi are formed 
between the hepatocytes in concert with changes in cytoskeleton distribution and 
localization of bile canaliculi transporter MRP2 into the apical domain [19, 36]. The 
cytoskeleton distribution in hepatocytes underwent dramatic changes upon the top 
support overlaying in both the synthetic sandwich culture and collagen sandwich culture: 
F-actin re-organized to the cell-cell contact region from its initial random distribution 12h 
after overlaying, which resembles the F-actin distribution in vivo  [34] (Fig. 28); 24h after 
overlaying, extensive and contiguous tight junctions between cells have been established 
with majority of the MRP2 co-localized to the bile canaliculi formed by contiguous cells, 
suggesting the preservation of the polarized phenotype (Fig. 28). Our observations 
indicate comparable hepatic polarity formation of the 3D hepatocyte monolayer in the 
synthetic sandwich culture as the hepatocytes in the collagen sandwich culture.  
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Fig. 28 Polarity formation in synthetic vs. collagen sandwich cultures: representative 
confocal images of F-actin staining and MRP2/CD147 double-staining of hepatocytes in 
both sandwich cultures before and after top support overlaying (Co-localization of the 
MRP2 to the bile canaliculi is marked by the arrows). 
 
The establishment of cell polarity and functional activity of bile canaliculi can be 
represented by the biliary excretion of hepatocytes, which is an important function of the 
liver to excrete metabolites and toxins from the body [7]. We examined the dynamic 
changes of hepatocyte biliary excretion in both sandwich cultures with a non-fluorescent 
substrate, fluorescein diacetate (FDA). FDA enters the cells via passive diffusion; and is 
hydrolyzed by intracellular esterases into fluorescein before excretion by bile canaliculi 
transporter (MRP2) [37]. The dynamics of FDA excretion from the 3D hepatocyte 
monolayer in the synthetic sandwich culture was similar to the observation from the 
hepatocytes in the collagen sandwich culture (Fig 29). In both sandwich cultures, there 
was nearly no fluorescein concentrated in bile canaliculi sacs between hepatocytes after 
12h overlaying of the top support; the fluorescein secreted into bile canaliculi sacs began 
to appear after 24h overlaying and fully developed between 48h and 72h (Fig. 29). The 
fluorescein localized in the inter-cellular sacs between hepatocytes was quantified by 
image processing (Fig. 29 and Fig. 30). The results indicate that the 3D hepatocyte 
monolayer in the synthetic sandwich culture exhibit similar extent of biliary excretion 
compared with the hepatocytes in the collagen sandwich culture. 
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Fig. 29 Biliary excretion of hepatocytes in synthetic vs. collagen sandwich cultures: 
representative confocal images of dynamic changes of fluorescein excreted by bile 
canaliculi transporter. The fluorescein localization in the inter-cellular sacs between 
hepatocytes is quantified as shown by the number at the corner of each image (using an 
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Fig. 30 Quantification of the biliary excretion of FDA with Image-pro Plus: (A) original 
confocal image of FDA staining; (B) segmented image of the original image; (C) signals, 
extracted from segmented image, representing total cell area; (D) signals, extracted from 
segmented image with different thresholds, representing secreted FDA. D1: lower 
threshold; D2: medium threshold; D3: higher threshold (the arrows indicate the highly-
fluorescent signals generated by FDA in the cytoplasm).  
 
 
Maintenance of hepatocyte differentiated functions in Synthetic vs. collagen sandwich 
culture  
We compared the key representative differentiated functions of hepatocytes in both 
sandwich cultures (Fig. 31). Albumin secretion, urea production and 7-ethoxyresorufin-
O-deethylation cytochrome P450 1A activity of 3D hepatocyte monolayer in the 
synthetic sandwich culture were significantly higher than that of the hepatocytes in the 
collagen sandwich culture over 14-days with the most dramatic enhancement observed 
within the first 4 to 6 days. The improvement in the hepatocyte functional maintenance in 
the synthetic sandwich culture may be due to the better cell-cell interaction of the 3D 
hepatocyte monolayer and improved mass transfer of nutrients and wastes removal across 
the synthetic top support. 
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Fig. 31 Hepatocyte functional maintenance in synthetic vs. collagen sandwich cultures as 
represented by: (A) Urea production; (B) Albumin secretion; (C) Normalized EROD 
cytochrome P450 1A detoxification activity relative to freshly isolated hepatocytes. ●: 
synthetic sandwich ▲: collagen sandwich. 
 
 
5.4   Conclusion and discussion  
 
We have established an ECM-free synthetic sandwich culture to stabilize the 3D 
hepatocyte monolayer between a GRGDS-modified PET TE membrane (top support) and 
a galactosylated PET film (bottom substratum). The 3D hepatocyte monolayer 
maintained in the synthetic sandwich culture exhibited similar polarity formation, 
improved mass transfer, enhanced cell-cell interactions and higher differeniated functions 
compared with the hepatocytes in the conventional collagen sandwich culture. The novel 
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synthetic sandwich culture can potentially be used as an alternative to the ECM-based 
sandwich culture for relevant hepatocyte-based applications in liver tissue engineering 
and drug discovery.  
The GRGDS-modified PET TE membrane top support may act as 1): a mechanical 
force applied to the hepatocytes from top, which might enhance the cell-substratum 
interaction and acts as a balance to the cell-cell interaction to stabilize the monolayer 
morphology [38]; 2) a physical boundary on top of the hepatocyte monolayer to confine 
the space, which prohibits the monolayer from folding into multilayer structure in 
spheroids; 3) a biochemical support with the immobilized bioactive components for 
morphological and functional improvement. As the non-modified PET TE membrane top 
support had little effect on stabilizing the hepatocyte monolayer and inducing the F-actin 
re-organization (Fig. 3A), we deduced that the immobilized bioactive ligand (galactose 
ligand or GRGDS peptide) on the top support play an essential role to achieve 
morphological and functional maintenance. It is known that the ligand-receptor 
interaction between the galactose and asialoglycoprotein receptor (ASGPR) was 
relatively weak [39] and hepatocytes cultured in galactosylated substrata tended to form 
multi-cellular spheroids [11]. RGD-integrin interactions have been shown to induce 
downstream signaling leading to the redistribution of the cytoskeleton, formation of focal 
adhesion complex, and enhancement of cell-cell interaction [40, 41]. Hepatocytes 
attached to RGD-modified substrata exhibit a spreading morphology as monolayer, with 
similar phenotypes as monolayer formed on collagen [42].When hepatocytes are exposed 
to GRGDS peptide or galactose ligand on the top support and galactose ligand on the 
bottom substratum in the synthetic sandwich culture, the synergistic interplay between 
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these two ligand-receptor interactions is expected. GRGDS-modified PET TE membrane 
(top support)/galactosylated PET film (bottom substratum) synthetic sandwich culture 
performed the best in terms of morphology stabilization, functional maintenance and 
polarity formation. GRGDS-modified PET TE membrane top support might induce the 
formation of focal adhesion complex on the top support, thus prevent the 3D spheroid 
formation and stabilize the 3D hepatocyte monolayer morphology. The galactosylated 
PET TE membrane top support has a poorer stabilization effect on the 3D hepatocyte 
monolayer, which might be caused by the weaker interaction between the galactose and 
ASGPR.  
We have also investigated the optimal procedure for overlaying the top support onto 
the 3D hepatocyte monolayer culture. Since the hepatocytes on the bottom PET-Gal film 
formed island-like clusters on day 1 after seeding and gradually merged into the 3D 
hepatocyte monolayer on day 2 [33], we overlaid the GRGDS-modified PET TE 
membrane top support on day 1 and day 2 respectively; and observed no distinct 
morphological differences over the 2-week culture (data not shown). We therefore 
overlaid the top support on day 1 to be consistent with the time of overlaying collagen top 
layer in the collagen sandwich culture. The hepatocytes within the synthetic sandwich 
culture are able to migrate laterally and interact with each other. 
The synthetic sandwich culture has exhibited several advantages over the 
conventional collagen sandwich: 1) minimizing mass transfer barrier caused by the 
gelled-ECM top layer, which hinders the exchange of nutrients, metabolites, xenobiotics 
or biochemical signals with the bulk of the medium; 2) mass transfer properties of the 
synthetic sandwich culture  could be readily controlled by choosing commercial PET TE 
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membranes with pore sizes from 0.1µm to 10µm and densities from 105 to 108 pores/cm2 
(the surface modification of the PET TE membrane with bioactive ligand will not affect 
the property of bulk material). The improved and controllable mass transfer achieved in 
the synthetic sandwich culture would be especially important for hepatocyte-based 
xenobiotics testing [43] and hepatocyte sandwich culture under perfusion condition in the 
bioreactor [44]; 3) 3D hepatocyte monolayer in synthetic sandwich culture exhibited 
enhanced cell-cell interaction and better differentiated functions maintained for two 
weeks compared to the hepatocytes in collagen sandwich culture, which may be partially 
due to the differences between the 3D hepatocyte monolayer on the galactosylated 
substrata and the 2D hepatocyte monolayer on the collagen substratum before overlaying 
of the top support. The specific galactose-ASGPR interaction may also play an active role 
to induce downstream cell-signaling for hepatocyte functional improvement; 4) More 
homogeneous hepatocyte morphology was observed in the synthetic sandwich culture 
than in the collagen sandwich culture, which might be due to the uniformity of the 
bioactive ligands exposed to the cells in the synthetic sandwich culture since it is not easy 
to produce uniform collagen coating on surfaces. The uniformity of hepatocyte behaviors 
would be important for mechanism studies using hepatocyte sandwich in vitro cultures, 
such as the studies of hepatic transport and biliary clearance responsible for the 
accumulation and excretion of a wide variety of drugs [7, 8]; We did not observe any 
significant difference in polarity formation and biliary excretion between the synthetic 
and collagen sandwich cultures indicating that the nature of the substrata may not be 
critical for hepatic polarities, as also mentioned by other studies [5, 8]. 
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Conclusions and directions for future investigation 
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6.1     Conclusions 
 
The thesis is based on the findings that hepatocytes cultured on a galactosylated 
PET film undergo multi-stage morphogenesis to form 3D hepatocyte spheroids; and there 
exists an interesting morphological stage before the formation of 3D spheroids, when the 
hepatocytes attach to the substrata as monolayer but exhibiting many characteristics of 
the 3D spheroids (such as well-established cell-cell/cell-matrix interactions, high levels 
of metabolic, synthetic, detoxification and excretory functions), but without the 
limitations of the 3D spheroids (such as poor mass transfer and un-even spatial 
distributions of cells with different characteristics). We coined the name of “3D 
hepatocyte monolayer” to indicate its monolayer morphology as well as 3D cell 
characteristics, which make it a promising novel hepatocyte culture model to improve the 
conventional 2D hepatocyte monolayer culture. Mechanistic studies revealed that the 
dynamic morphogenesis is mainly regulated by the balance between cell-cell interaction 
and cell-substratum interaction through cytoskeletal reorganization, which provided 
explanations for the existences of this 3D monolayer stage. Since the 3D hepatocyte 
monolayer is only a transient morphological stage existing less than two days, we 
employed two methods to achieve short-term and longer-term stabilization of the 3D 
hepatocyte monolayer respectively, which are readily useful for the related hepatocyte-
based applications.    
To achieve short-term stabilization of the 3D hepatocyte monolayer, GRGDS 
peptide and galactose ligand were co-conjugated on the PET film (PET-Hybrid). The 
stronger cell-substratum interaction mediated by the RGD-Integrin interaction selectively 
stabilizes the 3D hepatocyte monolayer stage on the PET-Hybrid up to one week, which 
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would be useful for various hepatocyte-based applications requiring both effective mass 
transfer and cellular support, especially in microplate-based drug metabolism/ 
hepatotoxicity studies. In the exemplary hepatotoxicity study, the 3D hepatocyte 
monolayer cultured on the PET-hybrid substratum exhibited a high level of sensitivity to 
hepatotoxicity induced by model drug. This sensitivity is similar to the 3D spheroids and 
higher than 2D hepatocyte monolayer cultured on collagen-coated substratum. The 
transparent PET-Hybrid film can be easily incorporated into microplate-based platform 
for high-throughput drug testing; and the 3D hepatocyte monolayer culture on the PET-
Hybrid is of commercial value as an improved hepatocyte culture model of 2D 
hepatocyte monolayer culture on ECM-coated substratum currently used by most Big 
Pharmas.  
For longer-term stabilization, a novel synthetic sandwich culture model was 
established to sandwich the 3D hepatocyte monolayer between the bottom galactosylated 
PET film and a top GRGDS-modified PET TE membrane. The top GRGDS-modified 
PET TE membrane provided chemical and mechanical supports to stabilize the 3D 
hepatocyte monolayer and achieve functional maintenance up to 2 weeks. The 3D 
hepatocyte monolayer maintained in the synthetic sandwich culture exhibited similar 
polarity formation, improved mass transfer, enhanced cell-cell interactions and higher 
differeniated functions compared with the hepatocytes in the conventional collagen 
sandwich culture. The novel synthetic sandwich culture can be potentially used as an 
alternative to the ECM-based sandwich culture for relevant hepatocyte-based applications, 
such as for drug chronic hepatotoxicity testing and for cell maintenance in bioreactor or 
bioartificial liver assisted devices. 
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6.2     Directions for future investigation   
 
The main direction for future investigation is to push the 3D hepatocyte monolayer 
culture model maintained within both the PET-Hybrid substratum and the synthetic 
sandwich culture into down-stream applications in liver tissue engineering field.  
Due to the readiness of the PET-Hybrid substratum to be incorporated into the 
microplate-based high-throughput automation platform, it can substitute for the ECM-
coated substratum to culture hepatocytes for xenobiotics/drug metabolism and 
hepatotoxicity testing. The 3D hepatocyte monolayer configuration is expected to provide 
improved in vitro prediction better recapitulating the in vivo biological responses. Besides 
the three model drugs tested in this thesis (all metabolism-mediated hepatotoxins), more 
xenobiotics/drugs could be tested to establish a portfolio or database of metabolism and 
hepatotoxicity profiles of particular drugs, which could be used for the prediction of 
unknown xenobiotics. The 3D hepatocyte monolayer model can also be used as a 
compartment corresponding to liver together with compartments from other organs in the 
physiologically-based pharmacokinetics studies. In addition, due to the uniformity of the 
3D hepatocyte monolayer maintained on the optically clear PET-Hybrid substratum, the 
system can also be potentially used as an alternative for ECM-coated substratum in the 
hepatocyte-based high content screening. This enables monitoring of multiple assay 
parameters (such as mitochondrial trans-membrane potential, intracellular free calcium, 
plasma membrane integrity) in one step and elucidating cellular events and response 
more mimic to hepatocytes in the liver. 
The 3D hepatocyte monolayer maintained in the synthetic sandwich culture is 
currently under investigation of being incorporated into a bioreactor developed by other 
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members in the lab for hepatocyte functional maintenance. The hepatocyte bioreactor will 
ultimately constitute a prototype for a BLAD to undergo animal testing. The synthetic 
sandwich culture is expected to achieve good mass transfer, functional/polarity 
maintenance, and toxin removal efficacy, which are critical for the success of the BLAD 
application. Future direction can also be employed to employ the 3D hepatocyte 
monolayer culture model in the synthetic sandwich for liver physiology and pathology 
studies, such as biliary excretion, ischemia- reperfusion injury, hepatitis C viral cirrhosis 
and hepatocellular carcinogenesis, etc.  
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Appendix: Invention disclosure 
1. PROPOSED SHORT TITLE OF INVENTION  
 
Stabilizing a novel 3D hepatocyte monolayer culture by a hybrid bioactive substratum for 
hepatocyte-based applications 
 
2. DESCRIPTION OF INVENTION     
(Please attach any draft manuscript, if available) 
In describing the Invention you should try to answer the question “what problem does 
the invention solve?” 
Primary hepatocytes have been widely used in bioartificial liver aided devices 
(BLAD), pharmacological, toxicological and metabolic studies. Hepatocytes in these 
applications are typically grown on appropriate substrata to achieve optimal cell 
attachment and functional maintenance. A variety of natural or synthetic polymeric 
substrata have been employed for hepatocytes culture (e.g. plastic surfaces or membranes 
coated with extracellular matrix proteins such as collagen, laminin, fibronectin or 
conjugated with cell adhesion peptides, such as Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-
Ser-Arg (YIGSR)). Hepatocytes anchor tightly to these substrata, and exhibit extended 
and spread cell morphology, with low levels of liver-specific functions likely due to 
hepatocyte de-differentiation. These substrata have been extensively used for drug 
screening in microplates as well as for bio-artificial liver bioreactors. Galactose-
conjugated bioactive substrata are attractive alternatives for hepatocyte attachment 
through the galactose-asialoglycoprotein receptor (ASGPR) interaction. Several strategies 
have been adopted to fabricate substrata conjugated with galactose ligands. Hepatocytes 
cultured on these galactosylated substrata tend to maintain round cell morphology and 
self-assemble into 3D spheroids. Hepatocytes spheroids with naturally formed 3D 
architecture showed well-established cell-cell/cell-matrix interactions and ideal liver-
specific functions, membrane polarities and liver ultra-structures which are believed to 
recreate an in vivo-like microenvironment. However, the usefulness of 3D hepatocyte 
spheroids in applications is limited due to the poor mass transport of nutrients, oxygen, 
xenobiotics and metabolites into and from the core of these large cellular aggregates. Cell 
loss is also a critical issue in forming and maintaining these spheroids in applications due 
to the poor adhesion of spheroids on the substratum.  
This invention is based on our recent novel finding (see example 1) that hepatocyte 
on galactose-conjugated bioactive substrata undergo 2 cycles of cell-aggregation and 
spreading to form large spheroids. Between the first and second cell-aggregation phases, 
there is this cell-spreading phase when the hepatocytes attach to the substrata as 
monolayer but exhibiting many characteristics of the 3D spheroids such as well-
established cell-cell/cell-matrix interactions, high levels of metabolic, synthetic, 
detoxification and excretory functions but without the above-described limitations of the 
3D spheroids such as poor mass transfer and un-even spatial distributions of cells with 
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different characteristics. We noticed that this cell-spreading phase (termed 3D hepatocyte 
monolayer) is transient between the two cell-aggregation phases, lasting only ~12 hrs. 
Thus, the aim of this invention is to stabilize the novel 3D hepatocyte monolayer in this 
cell-spreading phase over a period of up to a week so as to enable useful applications of 
this 3D hepatocyte monolayer in various hepatocyte-based applications.  
In order to achieve stabilization of this 3D hepatocyte monolayer for hepatocyte-
based applications, we have modified a bioactive galactosylated substratum with 
conjugated galactose ligand on polyethylene terephthalate (PET) film (U.S patent 
Application 20050058685) by co-conjugating RGD peptide and galactose onto the PET 
substratum (see sample 2). We hypothesize that the stronger cell-substratum interaction 
medicated by the RGD-Integrin interaction would selectively stabilize the cell-spreading 
3D monolayer phase. Indeed, we managed to stabilize the 3D monolayer structure on this 
hybrid substratum up to one week, which would be useful for various hepatocyte-based 
applications requiring both effective mass transfer and cellular support such as in drug 
metabolism/ hepatotoxicity studies or BLAD. In the exemplary hepatotoxicity study, the 
3D hepatocyte monolayer cultured on the hybrid substratum exhibits high level of 
sensitivity to hepatotoxicity induced by a model drug acetaminophen which is similar to 
the 3D spheroids and higher than 2D hepatocyte monolayer cultured on collagen-coated 
substratum.   
 
3. ADVANTAGE AND IMPROVEMENT OVER EXISTING TECHNOLOGY  
 
3(i) Are you aware of similar developments or research in this direct field? 
  No  
  
 Details: (Attach separate sheets if necessary) 
 
• Method of immobilization of clusers of ligands on polymer surface and use in cell 
engineering [Mao, Hai-Quan, Yin, Chao Zhuo, Ron-Xi; Leong, Kam W. United 
States Patent Application 20050058685] 
• Mixture of monolayer (50%-70%)) and 3D spheroids (30%-50%) cultured on 
Primaria dish (BD Bioscience) both with enhanced cytochrome P450 2B1/2 
activity than conventional monolayer on collagen-coated substrautm [Tzanakakis 
ES et al. Cell Transplant. 2001;10(3):329-42.]  
• Dexamethasone altered the kinetics of spheroid formation on the Primaria dish 
(BD Bioscience) in a concentration-dependent fashion, with increasing 
concentrations inhibiting aggregation and promoting a monolayer formation with 
high differentiated functions [Abu-Absi SF, Hu WS, Hansen LK., Tissue 
Engineering 2005 Mar-Apr;11(3-4):415-26] 
 
 
3(ii) What practical advantage does the invention provide over existing technology? 
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Identification of a pre-spheroid 3D hepatocyte monolayer and stabilization of this 
configuration by using the RGD/galactose hybrid substratum offer many advantages 
over the current 2D and 3D systems.   
 
• Compared with conventional 2D hepatocyte monolayer cultured on collagen-
coated substratum, 3D hepatocyte monolayer cultured on RGD/galactose hybrid 
substratum exhibited improved cellular structure and polarity, enhanced cell-cell 
interaction and better differentiated functions  
• 3D hepatocyte monolayer exhibited better attachment and mass transfer than 3D 
spheroids 
• Uniform monolayer morphology compared with the mixture of hepatocyte 
spheroids and monolayer on Primara dish [Tzanakakis ES et al. Cell Transplant. 
2001; 10:329-42.]  
• More effective mass transfer achieved in the ‘collagen-free’ bioactive sandwich 
culture configuration  
• Simple and quantitative controllable bioactive cues in the synthetic polymeric 
biomaterials compared to natural extracellular matrix with unidentified 
component and batch-to-batch variation  
• Chemically and mechanically stable for long-term storage and cryopreservation  
• Hepatocytes cultured in normal culture medium without exposure to high-level of 
hormone compared to the highly functional monolayer cultured on Primara dish 
maintained by high concentration of DEX   
• Biocompatible and optically clear, which is ready to be adapted to the micro-
plate-based ADME/TOX screening platform or membrane-based bioreactor 
• Same technology of conjugating multiple ligands onto PET film can be used to 
conjugate other bioactive ligands to better mimic basement membrane 
compositions for hepatocyte-based applications 
• The claims should try to cover 1) any applications utilizing this pre-spheroid 3D 
hepatocyte monolayer; and 2) any method of stabilizing this pre-spheroid 3D 
hepatocyte monolayer by chemical modifications of any surfaces. 
 
3(iii) Please provide references to what you consider to be the closest published work 
(inc. your own) to the new invention. 
 
• Cell culture support containing a cell adhesion factor and a positively-carged 
molecule [Clapper DL and H WS. US Patent 5,512,474] 
 
• Immobilization of galactose ligands on acrylic acid graft-copolymerized 
poly(ethylene terephthalate) film and its application to hepatocyte culture. [Ying 
L, Yin C, Zhuo RX, Leong KW, Mao HQ, Kang ET, et al., Biomacromolecules 
2003 Jan-Feb;4(1):157-165] 
 
• Mechanistic study of hepatocyte spheroids formation on Primaria dish 
[Tzanakakis ES, Hansen LK, Hu WS. Cell Motil Cytoskeleton. 2001 
Mar;48(3):175-89.] 
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4. EXPLOITATION STRATEGY: Potential Commercial Applications 
 
Indicate the possible commercial applications of the invention, either in the short or 
long term. 
 
With its effective adhesion to the substratum and 3D cell characteristic, the pre-
spheriod 3D hepatocyte monolayer stabilized on the RGD/galactose hybrid 
substratum can be useful in, but not limited to the following typical applications: 
 
1. Hepatocyte-based high throughput xenobiotics metabolism or hepato-toxicity 
screening (AP. Li Drug Discovery Today 2005; 2: 179-185; White RE. Annu 
Rev Pharmacol Toxicol. 2000;40:133-57; Battersby BJ. Trends Biotechnol. 
2002;20:167-73)   
 
ADME/T drug properties, namely, absorption, disposition, metabolism, 
elimination and toxicity, are important drug properties critical for clinical success. 
Accurate prediction of drug ADME/T remains the major challenge for the 
pharmaceutical industry. The routine practice of preclinical and clinical drug 
ADME/T evaluation is apparently inadequate, as evidenced by the yearly 
withdrawal or severe use limitation of marketed drugs due to unexpected adverse 
effects. As the parenchymal cell of liver, the main organ of biotransformation and 
detoxification of xenobiotics including drugs, hepatocyte-based drug screenings 
have been widely used to evaluate the metabolism and toxicity of the drug 
candidates. Most of the current hepatocyte-based high throughput 
metabolism/hepatotoxicity screenings of xenobiotics are done by using 
hepatocytes cultured on the collagen type I coated 96 well or 384 well microplates 
due to the easiness and consistency of the substrate preparation. Several other in 
vitro culture configuration have been tried to improve the functionality and 
biomimicry of the hepatocyte-based system, i.e. 3-D microcapsule, sandwich 
cultures, 3D spheroids culture micro-carrier culture, perfusion culture inside 
bioreactors and co-culture with non-parenchymal cells. However, those complex 
systems suffered from the technical complexity not easily adaptable to the 
standard HT screening platforms, which provide automation and instrumentation 
that supports parallel processes, such as plate-handling robots, high-density 
microplates and plate-scanning readers for the dye-based assays. 
 
With its chemical and mechanical stability and quantitatively controllable 
bioactive cues, the transparent hybrid polymeric substratum with 3D hepatocyte 
monolayer is easily and readily incorporated into the current microplate-based 
automation platform for high-throughput drug metabolism/hepatotoxicity 
screening as an alternative for collagen-coated substratum. The 3D hepatocyte 
monolayer configuration is expected to provide improved in vitro prediction of 
the xenobiotics pharmaco-kinetics/dynamics data that better recapitulate the in 
vivo biological responses.  
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The novel hybid RGD/galactose substratum, which can maintain pre-spheriod 3D 
monolayer for up to one week, can be potentially interesting for micro-plate 
manufacturers for hepatocyte-based high-throughput drug discovery, such as 
NUNC, Corning and BD Bioscience.   
 
2. Hepatocyte-based high content screening of biological responses to 
xenobiotics (Giuliano KA et al. Assay Drug Dev Technol. 2003; 1:565-77; 
Lang P. et al. Nat Rev Drug Discov. 2006;5:343-56) 
 
High-content screening is a high throughput approach applicable to cell-based 
systems that refers to the analysis of cellular assays using automated, image-based 
technology. This enables monitoring of multiple assay parameters, as well as 
capturing cellular information in one step — including cell shape and viability, 
target movement and interaction of the compound with other biomolecules. The 
difference is a few data points per well using a typical end-point analysis versus 
thousands per well using a 2-D imager. Thus, a high-content approach can reduce 
the cost of cell-based screening because many cellular features can be tracked at 
once. 
 
Due to the uniformity of the 3D hepatocyte monolayer maintained on the optically 
clear hybrid bioactive RGD/galactose substratum, the system can also be 
potentially used as an alternative for collagen-coated substratum in the 
hepatocyte-based high content screening. This enables monitoring of multiple 
assay parameters (such as mitochondrial trans-membrane potential, intracellular 
free calcium, plasma membrane integrity) in one step and elucidating cellular 
events and response more mimic to hepatocytes in the liver. The developers of 
high-content screening system such as Cellomics, TTP, Evotec, Molecular 
Devices and GE-Healthcare may be interested in this invention. 
 
 
3. Model system to study the mechanism of tissue morphogenesis  
 
The ability to understand and control the morphogenesis of 3D tissue-like 
structures is a fundamental objective of cell and developmental biology and tissue 
engineering research. Hepatocyte spheroid formation involves cell translocation 
and changes in cell shape that mimic the process of tissue formation. The capacity 
to regulate hepatocytes spheroids formation by the bioactive ligands in the hybrid 
polymeric substratum enables the mechanism study of spheroid formation, which 
is useful for revealing invaluable clues regarding the principles of how cells 
organize into the structured tissues. 
 
 
4. As “supporting surface” for bio-artificial liver bioreactor  
 
Bioreactor in bio-artificial liver devices can be in any suitable form, such as 
membrane, tubes, microtitier wells, columns, hollow fibers, roller bottlers, plates, 
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and microcarriers. The “supporting surface” of a bioreactor is intended to 
physically contact and support the attachment of the cells. Suitable support 
materials provide a surface that exhibits an optimal combination of such 
properties as rigidity, surface area, ease of preparation and use, and cost.  
 
This invention relates to cell culture surfaces of bioreactors in the field of liver 
tissue engineering and particularly to methods of improving the surfaces to obtain 
3D hepatocyte monolayer, a novel culture configuration with better cell 
attachment and function. We are developing a bio-artificial liver bioreactor that 
will adopt this invention as a component. Thus, a spin-off company dealing with 
bio-artificial liver will likely license this invention, in addition to other existing 
companies developing other liver devices, such as Johnson & Johnson. 
 
 
